Endpoints News – Biotech and pharma business news, with a focus on the science, people and money that drive the industry.

<!DOCTYPE html> <html lang="en"> <head> <meta charset="UTF-8"/><script type="text/javascript">(window.NREUM||(NREUM={})).init={ajax:{deny_list:["bam.nr-data.net"]}};(window.NREUM||(NREUM={})).loader_config={licenseKey:"NRJS-0a161597335a680ce50",applicationID:"717633112"};;/*! For license information please see nr-loader-rum-1.274.0.min.js.LICENSE.txt */ (()=>{var e,t,r={8122:(e,t,r)=>{"use strict";r.d(t,{a:()=>i});var n=r(944);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.R)(3);if(!t||"object"!=typeof t)return(0,n.R)(4);const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{if(null===e[a]){r[a]=null;continue}Array.isArray(e[a])&&Array.isArray(t[a])?r[a]=Array.from(new Set([...e[a],...t[a]])):"object"==typeof e[a]&&"object"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){(0,n.R)(1,e)}return r}catch(e){(0,n.R)(2,e)}}},2555:(e,t,r)=>{"use strict";r.d(t,{Vp:()=>c,fn:()=>s,x1:()=>u});var n=r(384),i=r(8122);const o={beacon:n.NT.beacon,errorBeacon:n.NT.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0},a={};function s(e){try{const t=c(e);return!!t.licenseKey&&!!t.errorBeacon&&!!t.applicationID}catch(e){return!1}}function c(e){if(!e)throw new Error("All info objects require an agent identifier!");if(!a[e])throw new Error("Info for ".concat(e," was never set"));return a[e]}function u(e,t){if(!e)throw new Error("All info objects require an agent identifier!");a[e]=(0,i.a)(t,o);const r=(0,n.nY)(e);r&&(r.info=a[e])}},9417:(e,t,r)=>{"use strict";r.d(t,{D0:()=>g,gD:()=>h,xN:()=>p});var n=r(993);const i=e=>{if(!e||"string"!=typeof e)return!1;try{document.createDocumentFragment().querySelector(e)}catch{return!1}return!0};var o=r(2614),a=r(944),s=r(384),c=r(8122);const u="[data-nr-mask]",d=()=>{const e={mask_selector:"*",block_selector:"[data-nr-block]",mask_input_options:{color:!1,date:!1,"datetime-local":!1,email:!1,month:!1,number:!1,range:!1,search:!1,tel:!1,text:!1,time:!1,url:!1,week:!1,textarea:!1,select:!1,password:!0}};return{ajax:{deny_list:void 0,block_internal:!0,enabled:!0,harvestTimeSeconds:10,autoStart:!0},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},feature_flags:[],generic_events:{enabled:!0,harvestTimeSeconds:30,autoStart:!0},harvest:{tooManyRequestsDelay:60},jserrors:{enabled:!0,harvestTimeSeconds:10,autoStart:!0},logging:{enabled:!0,harvestTimeSeconds:10,autoStart:!0,level:n.p_.INFO},metrics:{enabled:!0,autoStart:!0},obfuscate:void 0,page_action:{enabled:!0},page_view_event:{enabled:!0,autoStart:!0},page_view_timing:{enabled:!0,harvestTimeSeconds:30,autoStart:!0},performance:{capture_marks:!1,capture_measures:!1},privacy:{cookies_enabled:!0},proxy:{assets:void 0,beacon:void 0},session:{expiresMs:o.wk,inactiveMs:o.BB},session_replay:{autoStart:!0,enabled:!1,harvestTimeSeconds:60,preload:!1,sampling_rate:10,error_sampling_rate:100,collect_fonts:!1,inline_images:!1,fix_stylesheets:!0,mask_all_inputs:!0,get mask_text_selector(){return e.mask_selector},set mask_text_selector(t){i(t)?e.mask_selector="".concat(t,",").concat(u):""===t||null===t?e.mask_selector=u:(0,a.R)(5,t)},get block_class(){return"nr-block"},get ignore_class(){return"nr-ignore"},get mask_text_class(){return"nr-mask"},get block_selector(){return e.block_selector},set block_selector(t){i(t)?e.block_selector+=",".concat(t):""!==t&&(0,a.R)(6,t)},get mask_input_options(){return e.mask_input_options},set mask_input_options(t){t&&"object"==typeof t?e.mask_input_options={...t,password:!0}:(0,a.R)(7,t)}},session_trace:{enabled:!0,harvestTimeSeconds:10,autoStart:!0},soft_navigations:{enabled:!0,harvestTimeSeconds:10,autoStart:!0},spa:{enabled:!0,harvestTimeSeconds:10,autoStart:!0},ssl:void 0,user_actions:{enabled:!0}}},l={},f="All configuration objects require an agent identifier!";function g(e){if(!e)throw new Error(f);if(!l[e])throw new Error("Configuration for ".concat(e," was never set"));return l[e]}function p(e,t){if(!e)throw new Error(f);l[e]=(0,c.a)(t,d());const r=(0,s.nY)(e);r&&(r.init=l[e])}function h(e,t){if(!e)throw new Error(f);var r=g(e);if(r){for(var n=t.split("."),i=0;i<n.length-1;i++)if("object"!=typeof(r=r[n[i]]))return;r=r[n[n.length-1]]}return r}},3371:(e,t,r)=>{"use strict";r.d(t,{V:()=>f,f:()=>l});var n=r(8122),i=r(384),o=r(6154),a=r(9324);let s=0;const c={buildEnv:a.F3,distMethod:a.Xs,version:a.xv,originTime:o.WN},u={customTransaction:void 0,disabled:!1,isolatedBacklog:!1,loaderType:void 0,maxBytes:3e4,onerror:void 0,ptid:void 0,releaseIds:{},appMetadata:{},session:void 0,denyList:void 0,timeKeeper:void 0,obfuscator:void 0},d={};function l(e){if(!e)throw new Error("All runtime objects require an agent identifier!");if(!d[e])throw new Error("Runtime for ".concat(e," was never set"));return d[e]}function f(e,t){if(!e)throw new Error("All runtime objects require an agent identifier!");d[e]={...(0,n.a)(t,u),...c},Object.hasOwnProperty.call(d[e],"harvestCount")||Object.defineProperty(d[e],"harvestCount",{get:()=>++s});const r=(0,i.nY)(e);r&&(r.runtime=d[e])}},9324:(e,t,r)=>{"use strict";r.d(t,{F3:()=>i,Xs:()=>o,xv:()=>n});const n="1.274.0",i="PROD",o="CDN"},6154:(e,t,r)=>{"use strict";r.d(t,{OF:()=>c,RI:()=>i,WN:()=>d,bv:()=>o,gm:()=>a,mw:()=>s,sb:()=>u});var n=r(1863);const i="undefined"!=typeof window&&!!window.document,o="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),a=i?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),s=Boolean("hidden"===a?.document?.visibilityState),c=/iPad|iPhone|iPod/.test(a.navigator?.userAgent),u=c&&"undefined"==typeof SharedWorker,d=((()=>{const e=a.navigator?.userAgent?.match(/Firefox[/\s](\d+\.\d+)/);Array.isArray(e)&&e.length>=2&&e[1]})(),Date.now()-(0,n.t)())},1687:(e,t,r)=>{"use strict";r.d(t,{Ak:()=>c,Ze:()=>l,x3:()=>u});var n=r(7836),i=r(3606),o=r(860),a=r(2646);const s={};function c(e,t){const r={staged:!1,priority:o.P3[t]||0};d(e),s[e].get(t)||s[e].set(t,r)}function u(e,t){e&&s[e]&&(s[e].get(t)&&s[e].delete(t),g(e,t,!1),s[e].size&&f(e))}function d(e){if(!e)throw new Error("agentIdentifier required");s[e]||(s[e]=new Map)}function l(e="",t="feature",r=!1){if(d(e),!e||!s[e].get(t)||r)return g(e,t);s[e].get(t).staged=!0,f(e)}function f(e){const t=Array.from(s[e]);t.every((([e,t])=>t.staged))&&(t.sort(((e,t)=>e[1].priority-t[1].priority)),t.forEach((([t])=>{s[e].delete(t),g(e,t)})))}function g(e,t,r=!0){const o=e?n.ee.get(e):n.ee,s=i.i.handlers;if(!o.aborted&&o.backlog&&s){if(r){const e=o.backlog[t],r=s[t];if(r){for(let t=0;e&&t<e.length;++t)p(e[t],r);Object.entries(r).forEach((([e,t])=>{Object.values(t||{}).forEach((t=>{t[0]?.on&&t[0]?.context()instanceof a.y&&t[0].on(e,t[1])}))}))}}o.isolatedBacklog||delete s[t],o.backlog[t]=null,o.emit("drain-"+t,[])}}function p(e,t){var r=e[1];Object.values(t[r]||{}).forEach((t=>{var r=e[0];if(t[0]===r){var n=t[1],i=e[3],o=e[2];n.apply(i,o)}}))}},7836:(e,t,r)=>{"use strict";r.d(t,{P:()=>c,ee:()=>u});var n=r(384),i=r(8990),o=r(3371),a=r(2646),s=r(5607);const c="nr@context:".concat(s.W),u=function e(t,r){var n={},s={},d={},l=!1;try{l=16===r.length&&(0,o.f)(r).isolatedBacklog}catch(e){}var f={on:p,addEventListener:p,removeEventListener:function(e,t){var r=n[e];if(!r)return;for(var i=0;i<r.length;i++)r[i]===t&&r.splice(i,1)},emit:function(e,r,n,i,o){!1!==o&&(o=!0);if(u.aborted&&!i)return;t&&o&&t.emit(e,r,n);for(var a=g(n),c=h(e),d=c.length,l=0;l<d;l++)c[l].apply(a,r);var p=m()[s[e]];p&&p.push([f,e,r,a]);return a},get:v,listeners:h,context:g,buffer:function(e,t){const r=m();if(t=t||"feature",f.aborted)return;Object.entries(e||{}).forEach((([e,n])=>{s[n]=t,t in r||(r[t]=[])}))},abort:function(){f._aborted=!0,Object.keys(f.backlog).forEach((e=>{delete f.backlog[e]}))},isBuffering:function(e){return!!m()[s[e]]},debugId:r,backlog:l?{}:t&&"object"==typeof t.backlog?t.backlog:{},isolatedBacklog:l};return Object.defineProperty(f,"aborted",{get:()=>{let e=f._aborted||!1;return e||(t&&(e=t.aborted),e)}}),f;function g(e){return e&&e instanceof a.y?e:e?(0,i.I)(e,c,(()=>new a.y(c))):new a.y(c)}function p(e,t){n[e]=h(e).concat(t)}function h(e){return n[e]||[]}function v(t){return d[t]=d[t]||e(f,t)}function m(){return f.backlog}}(void 0,"globalEE"),d=(0,n.Zm)();d.ee||(d.ee=u)},2646:(e,t,r)=>{"use strict";r.d(t,{y:()=>n});class n{constructor(e){this.contextId=e}}},9908:(e,t,r)=>{"use strict";r.d(t,{d:()=>n,p:()=>i});var n=r(7836).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},3606:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(9908);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.d,i,e,t,r)}function a(e,t,r,i,o){o||(o="feature"),e||(e=n.d);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3878:(e,t,r)=>{"use strict";function n(e,t){return{capture:e,passive:!1,signal:t}}function i(e,t,r=!1,i){window.addEventListener(e,t,n(r,i))}function o(e,t,r=!1,i){document.addEventListener(e,t,n(r,i))}r.d(t,{DD:()=>o,jT:()=>n,sp:()=>i})},5607:(e,t,r)=>{"use strict";r.d(t,{W:()=>n});const n=(0,r(9566).bz)()},9566:(e,t,r)=>{"use strict";r.d(t,{LA:()=>s,bz:()=>a});var n=r(6154);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n.gm?.crypto||n.gm?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(30))),i.split("").map((e=>"x"===e?o(t,r++).toString(16):"y"===e?(3&o()|8).toString(16):e)).join("")}function s(e){const t=n.gm?.crypto||n.gm?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(e)));const a=[];for(var s=0;s<e;s++)a.push(o(r,i++).toString(16));return a.join("")}},2614:(e,t,r)=>{"use strict";r.d(t,{BB:()=>a,H3:()=>n,g:()=>u,iL:()=>c,tS:()=>s,uh:()=>i,wk:()=>o});const n="NRBA",i="SESSION",o=144e5,a=18e5,s={STARTED:"session-started",PAUSE:"session-pause",RESET:"session-reset",RESUME:"session-resume",UPDATE:"session-update"},c={SAME_TAB:"same-tab",CROSS_TAB:"cross-tab"},u={OFF:0,FULL:1,ERROR:2}},1863:(e,t,r)=>{"use strict";function n(){return Math.floor(performance.now())}r.d(t,{t:()=>n})},944:(e,t,r)=>{"use strict";function n(e,t){"function"==typeof console.debug&&console.debug("New Relic Warning: https://github.com/newrelic/newrelic-browser-agent/blob/main/docs/warning-codes.md#".concat(e),t)}r.d(t,{R:()=>n})},5284:(e,t,r)=>{"use strict";r.d(t,{t:()=>c,B:()=>s});var n=r(7836),i=r(6154);const o="newrelic";const a=new Set,s={};function c(e,t){const r=n.ee.get(t);s[t]??={},e&&"object"==typeof e&&(a.has(t)||(r.emit("rumresp",[e]),s[t]=e,a.add(t),function(e={}){try{i.gm.dispatchEvent(new CustomEvent(o,{detail:e}))}catch(e){}}({loaded:!0})))}},8990:(e,t,r)=>{"use strict";r.d(t,{I:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},6389:(e,t,r)=>{"use strict";function n(e,t=500,r={}){const n=r?.leading||!1;let i;return(...r)=>{n&&void 0===i&&(e.apply(this,r),i=setTimeout((()=>{i=clearTimeout(i)}),t)),n||(clearTimeout(i),i=setTimeout((()=>{e.apply(this,r)}),t))}}function i(e){let t=!1;return(...r)=>{t||(t=!0,e.apply(this,r))}}r.d(t,{J:()=>i,s:()=>n})},5289:(e,t,r)=>{"use strict";r.d(t,{GG:()=>o,sB:()=>a});var n=r(3878);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.sp)("load",e,t)}function a(e){if(i())return e();(0,n.DD)("DOMContentLoaded",e)}},384:(e,t,r)=>{"use strict";r.d(t,{NT:()=>o,US:()=>d,Zm:()=>a,bQ:()=>c,dV:()=>s,nY:()=>u,pV:()=>l});var n=r(6154),i=r(1863);const o={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return n.gm.NREUM||(n.gm.NREUM={}),void 0===n.gm.newrelic&&(n.gm.newrelic=n.gm.NREUM),n.gm.NREUM}function s(){let e=a();return e.o||(e.o={ST:n.gm.setTimeout,SI:n.gm.setImmediate,CT:n.gm.clearTimeout,XHR:n.gm.XMLHttpRequest,REQ:n.gm.Request,EV:n.gm.Event,PR:n.gm.Promise,MO:n.gm.MutationObserver,FETCH:n.gm.fetch,WS:n.gm.WebSocket}),e}function c(e,t){let r=a();r.initializedAgents??={},t.initializedAt={ms:(0,i.t)(),date:new Date},r.initializedAgents[e]=t}function u(e){let t=a();return t.initializedAgents?.[e]}function d(e,t){a()[e]=t}function l(){return function(){let e=a();const t=e.info||{};e.info={beacon:o.beacon,errorBeacon:o.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),s(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},2843:(e,t,r)=>{"use strict";r.d(t,{u:()=>i});var n=r(3878);function i(e,t=!1,r,i){(0,n.DD)("visibilitychange",(function(){if(t)return void("hidden"===document.visibilityState&&e());e(document.visibilityState)}),r,i)}},3434:(e,t,r)=>{"use strict";r.d(t,{YM:()=>c});var n=r(7836),i=r(5607);const o="nr@original:".concat(i.W);var a=Object.prototype.hasOwnProperty,s=!1;function c(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");const a="-"===n.charAt(0);for(let s=0;s<t.length;s++){const c=t[s],u=e[c];d(u)||(e[c]=r(u,a?c+n:n,i,c,o))}},r.flag=o,r;function r(t,r,n,s,c){return d(t)?t:(r||(r=""),nrWrapper[o]=t,function(e,t,r){if(Object.defineProperty&&Object.keys)try{return Object.keys(e).forEach((function(r){Object.defineProperty(t,r,{get:function(){return e[r]},set:function(t){return e[r]=t,t}})})),t}catch(e){u([e],r)}for(var n in e)a.call(e,n)&&(t[n]=e[n])}(t,nrWrapper,e),nrWrapper);function nrWrapper(){var o,a,d,l;try{a=this,o=[...arguments],d="function"==typeof n?n(o,a):n||{}}catch(t){u([t,"",[o,a,s],d],e)}i(r+"start",[o,a,s],d,c);try{return l=t.apply(a,o)}catch(e){throw i(r+"err",[o,a,e],d,c),e}finally{i(r+"end",[o,a,l],d,c)}}}function i(r,n,i,o){if(!s||t){var a=s;s=!0;try{e.emit(r,n,i,t,o)}catch(t){u([t,r,n,i],e)}s=a}}}function u(e,t){t||(t=n.ee);try{t.emit("internal-error",e)}catch(e){}}function d(e){return!(e&&"function"==typeof e&&e.apply&&!e[o])}},993:(e,t,r)=>{"use strict";r.d(t,{ET:()=>o,p_:()=>i});var n=r(860);const i={ERROR:"ERROR",WARN:"WARN",INFO:"INFO",DEBUG:"DEBUG",TRACE:"TRACE"},o="log";n.K7.logging},3969:(e,t,r)=>{"use strict";r.d(t,{TZ:()=>n,XG:()=>s,rs:()=>i,xV:()=>a,z_:()=>o});const n=r(860).K7.metrics,i="sm",o="cm",a="storeSupportabilityMetrics",s="storeEventMetrics"},6630:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewEvent},782:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewTiming},6344:(e,t,r)=>{"use strict";r.d(t,{G4:()=>i});var n=r(2614);r(860).K7.sessionReplay;const i={RECORD:"recordReplay",PAUSE:"pauseReplay",REPLAY_RUNNING:"replayRunning",ERROR_DURING_REPLAY:"errorDuringReplay"};n.g.ERROR,n.g.FULL,n.g.OFF},4234:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(7836),i=r(1687);class o{constructor(e,t){this.agentIdentifier=e,this.ee=n.ee.get(e),this.featureName=t,this.blocked=!1}deregisterDrain(){(0,i.x3)(this.agentIdentifier,this.featureName)}}},7603:(e,t,r)=>{"use strict";r.d(t,{j:()=>P});var n=r(860),i=r(2555),o=r(3371),a=r(9908),s=r(7836),c=r(1687),u=r(5289),d=r(6154),l=r(944),f=r(3969),g=r(384),p=r(6344);const h=["setErrorHandler","finished","addToTrace","addRelease","addPageAction","setCurrentRouteName","setPageViewName","setCustomAttribute","interaction","noticeError","setUserId","setApplicationVersion","start",p.G4.RECORD,p.G4.PAUSE,"log","wrapLogger"],v=["setErrorHandler","finished","addToTrace","addRelease"];var m=r(1863),b=r(2614),y=r(993);var w=r(2646),A=r(3434);function R(e,t,r,n){if("object"!=typeof t||!t||"string"!=typeof r||!r||"function"!=typeof t[r])return(0,l.R)(29);const i=function(e){return(e||s.ee).get("logger")}(e),o=(0,A.YM)(i),a=new w.y(s.P);return a.level=n.level,a.customAttributes=n.customAttributes,o.inPlace(t,[r],"wrap-logger-",a),i}function E(){const e=(0,g.pV)();h.forEach((t=>{e[t]=(...r)=>function(t,...r){let n=[];return Object.values(e.initializedAgents).forEach((e=>{e&&e.api?e.exposed&&e.api[t]&&n.push(e.api[t](...r)):(0,l.R)(38,t)})),n.length>1?n:n[0]}(t,...r)}))}const x={};function _(e,t,g=!1){t||(0,c.Ak)(e,"api");const h={};var w=s.ee.get(e),A=w.get("tracer");x[e]=b.g.OFF,w.on(p.G4.REPLAY_RUNNING,(t=>{x[e]=t}));var E="api-",_=E+"ixn-";function N(t,r,n,o){const a=(0,i.Vp)(e);return null===r?delete a.jsAttributes[t]:(0,i.x1)(e,{...a,jsAttributes:{...a.jsAttributes,[t]:r}}),j(E,n,!0,o||null===r?"session":void 0)(t,r)}function T(){}h.log=function(e,{customAttributes:t={},level:r=y.p_.INFO}={}){(0,a.p)(f.xV,["API/log/called"],void 0,n.K7.metrics,w),function(e,t,r={},i=y.p_.INFO){(0,a.p)(f.xV,["API/logging/".concat(i.toLowerCase(),"/called")],void 0,n.K7.metrics,e),(0,a.p)(y.ET,[(0,m.t)(),t,r,i],void 0,n.K7.logging,e)}(w,e,t,r)},h.wrapLogger=(e,t,{customAttributes:r={},level:i=y.p_.INFO}={})=>{(0,a.p)(f.xV,["API/wrapLogger/called"],void 0,n.K7.metrics,w),R(w,e,t,{customAttributes:r,level:i})},v.forEach((e=>{h[e]=j(E,e,!0,"api")})),h.addPageAction=j(E,"addPageAction",!0,n.K7.genericEvents),h.setPageViewName=function(t,r){if("string"==typeof t)return"/"!==t.charAt(0)&&(t="/"+t),(0,o.f)(e).customTransaction=(r||"http://custom.transaction")+t,j(E,"setPageViewName",!0)()},h.setCustomAttribute=function(e,t,r=!1){if("string"==typeof e){if(["string","number","boolean"].includes(typeof t)||null===t)return N(e,t,"setCustomAttribute",r);(0,l.R)(40,typeof t)}else(0,l.R)(39,typeof e)},h.setUserId=function(e){if("string"==typeof e||null===e)return N("enduser.id",e,"setUserId",!0);(0,l.R)(41,typeof e)},h.setApplicationVersion=function(e){if("string"==typeof e||null===e)return N("application.version",e,"setApplicationVersion",!1);(0,l.R)(42,typeof e)},h.start=()=>{try{(0,a.p)(f.xV,["API/start/called"],void 0,n.K7.metrics,w),w.emit("manual-start-all")}catch(e){(0,l.R)(23,e)}},h[p.G4.RECORD]=function(){(0,a.p)(f.xV,["API/recordReplay/called"],void 0,n.K7.metrics,w),(0,a.p)(p.G4.RECORD,[],void 0,n.K7.sessionReplay,w)},h[p.G4.PAUSE]=function(){(0,a.p)(f.xV,["API/pauseReplay/called"],void 0,n.K7.metrics,w),(0,a.p)(p.G4.PAUSE,[],void 0,n.K7.sessionReplay,w)},h.interaction=function(e){return(new T).get("object"==typeof e?e:{})};const S=T.prototype={createTracer:function(e,t){var r={},i=this,o="function"==typeof t;return(0,a.p)(f.xV,["API/createTracer/called"],void 0,n.K7.metrics,w),g||(0,a.p)(_+"tracer",[(0,m.t)(),e,r],i,n.K7.spa,w),function(){if(A.emit((o?"":"no-")+"fn-start",[(0,m.t)(),i,o],r),o)try{return t.apply(this,arguments)}catch(e){const t="string"==typeof e?new Error(e):e;throw A.emit("fn-err",[arguments,this,t],r),t}finally{A.emit("fn-end",[(0,m.t)()],r)}}}};function j(e,t,r,i){return function(){return(0,a.p)(f.xV,["API/"+t+"/called"],void 0,n.K7.metrics,w),i&&(0,a.p)(e+t,[(0,m.t)(),...arguments],r?null:this,i,w),r?void 0:this}}function k(){r.e(296).then(r.bind(r,8778)).then((({setAPI:t})=>{t(e),(0,c.Ze)(e,"api")})).catch((e=>{(0,l.R)(27,e),w.abort()}))}return["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach((e=>{S[e]=j(_,e,void 0,g?n.K7.softNav:n.K7.spa)})),h.setCurrentRouteName=g?j(_,"routeName",void 0,n.K7.softNav):j(E,"routeName",!0,n.K7.spa),h.noticeError=function(t,r){"string"==typeof t&&(t=new Error(t)),(0,a.p)(f.xV,["API/noticeError/called"],void 0,n.K7.metrics,w),(0,a.p)("err",[t,(0,m.t)(),!1,r,!!x[e]],void 0,n.K7.jserrors,w)},d.RI?(0,u.GG)((()=>k()),!0):k(),h}var N=r(9417),T=r(8122);const S={accountID:void 0,trustKey:void 0,agentID:void 0,licenseKey:void 0,applicationID:void 0,xpid:void 0},j={};var k=r(5284);const I=e=>{const t=e.startsWith("http");e+="/",r.p=t?e:"https://"+e};let O=!1;function P(e,t={},r,n){let{init:a,info:c,loader_config:u,runtime:l={},exposed:f=!0}=t;l.loaderType=r;const p=(0,g.pV)();c||(a=p.init,c=p.info,u=p.loader_config),(0,N.xN)(e.agentIdentifier,a||{}),function(e,t){if(!e)throw new Error("All loader-config objects require an agent identifier!");j[e]=(0,T.a)(t,S);const r=(0,g.nY)(e);r&&(r.loader_config=j[e])}(e.agentIdentifier,u||{}),c.jsAttributes??={},d.bv&&(c.jsAttributes.isWorker=!0),(0,i.x1)(e.agentIdentifier,c);const h=(0,N.D0)(e.agentIdentifier),v=[c.beacon,c.errorBeacon];O||(h.proxy.assets&&(I(h.proxy.assets),v.push(h.proxy.assets)),h.proxy.beacon&&v.push(h.proxy.beacon),E(),(0,g.US)("activatedFeatures",k.B),e.runSoftNavOverSpa&&=!0===h.soft_navigations.enabled&&h.feature_flags.includes("soft_nav")),l.denyList=[...h.ajax.deny_list||[],...h.ajax.block_internal?v:[]],l.ptid=e.agentIdentifier,(0,o.V)(e.agentIdentifier,l),e.ee=s.ee.get(e.agentIdentifier),void 0===e.api&&(e.api=_(e.agentIdentifier,n,e.runSoftNavOverSpa)),void 0===e.exposed&&(e.exposed=f),O=!0}},8374:(e,t,r)=>{r.nc=(()=>{try{return document?.currentScript?.nonce}catch(e){}return""})()},860:(e,t,r)=>{"use strict";r.d(t,{$J:()=>o,K7:()=>n,P3:()=>i});const n={ajax:"ajax",genericEvents:"generic_events",jserrors:"jserrors",logging:"logging",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",softNav:"soft_navigations",spa:"spa"},i={[n.pageViewEvent]:1,[n.pageViewTiming]:2,[n.metrics]:3,[n.jserrors]:4,[n.spa]:5,[n.ajax]:6,[n.sessionTrace]:7,[n.softNav]:8,[n.sessionReplay]:9,[n.logging]:10,[n.genericEvents]:11},o={[n.pageViewTiming]:"events",[n.ajax]:"events",[n.spa]:"events",[n.softNav]:"events",[n.metrics]:"jserrors",[n.jserrors]:"jserrors",[n.sessionTrace]:"browser/blobs",[n.sessionReplay]:"browser/blobs",[n.logging]:"browser/logs",[n.genericEvents]:"ins"}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>"nr-rum-1.274.0.min.js",i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA-1.274.0.PROD:",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d<u.length;d++){var l=u[d];if(l.getAttribute("src")==r||l.getAttribute("data-webpack")==t+o){s=l;break}}if(!s){c=!0;var f={296:"sha512-gkYkZDAwQ9PwaDXs2YM+rNIdRej1Ac1mupWobRJ8eahQcXz6/sunGZCKklrzi5kWxhOGRZr2tn0rEKuLTXzfAA=="};(s=document.createElement("script")).charset="utf-8",s.timeout=120,i.nc&&s.setAttribute("nonce",i.nc),s.setAttribute("data-webpack",t+o),s.src=r,0!==s.src.indexOf(window.location.origin+"/")&&(s.crossOrigin="anonymous"),f[a]&&(s.integrity=f[a])}e[r]=[n];var g=(t,n)=>{s.onerror=s.onload=null,clearTimeout(p);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},p=setTimeout(g.bind(null,void 0,{type:"timeout",target:s}),12e4);s.onerror=g.bind(null,s.onerror),s.onload=g.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.p="https://js-agent.newrelic.com/",(()=>{var e={840:0,374:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),a=r&&r.target&&r.target.src;s.message="Loading chunk "+t+" failed.\n("+o+": "+a+")",s.name="ChunkLoadError",s.type=o,s.request=a,n[1](s)}}),"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u<a.length;u++)o=a[u],i.o(e,o)&&e[o]&&e[o][0](),e[o]=0},r=self["webpackChunk:NRBA-1.274.0.PROD"]=self["webpackChunk:NRBA-1.274.0.PROD"]||[];r.forEach(t.bind(null,0)),r.push=t.bind(null,r.push.bind(r))})(),(()=>{"use strict";i(8374);var e=i(944),t=i(6344),r=i(9566);class n{agentIdentifier;constructor(e=(0,r.LA)(16)){this.agentIdentifier=e}#e(t,...r){if("function"==typeof this.api?.[t])return this.api[t](...r);(0,e.R)(35,t)}addPageAction(e,t){return this.#e("addPageAction",e,t)}setPageViewName(e,t){return this.#e("setPageViewName",e,t)}setCustomAttribute(e,t,r){return this.#e("setCustomAttribute",e,t,r)}noticeError(e,t){return this.#e("noticeError",e,t)}setUserId(e){return this.#e("setUserId",e)}setApplicationVersion(e){return this.#e("setApplicationVersion",e)}setErrorHandler(e){return this.#e("setErrorHandler",e)}addRelease(e,t){return this.#e("addRelease",e,t)}log(e,t){return this.#e("log",e,t)}}class o extends n{#e(t,...r){if("function"==typeof this.api?.[t])return this.api[t](...r);(0,e.R)(35,t)}start(){return this.#e("start")}finished(e){return this.#e("finished",e)}recordReplay(){return this.#e(t.G4.RECORD)}pauseReplay(){return this.#e(t.G4.PAUSE)}addToTrace(e){return this.#e("addToTrace",e)}setCurrentRouteName(e){return this.#e("setCurrentRouteName",e)}interaction(){return this.#e("interaction")}wrapLogger(e,t,r){return this.#e("wrapLogger",e,t,r)}}var a=i(860),s=i(9417);const c=Object.values(a.K7);function u(e){const t={};return c.forEach((r=>{t[r]=function(e,t){return!0===(0,s.gD)(t,"".concat(e,".enabled"))}(r,e)})),t}var d=i(7603);var l=i(1687),f=i(4234),g=i(5289),p=i(6154),h=i(384);const v=e=>p.RI&&!0===(0,s.gD)(e,"privacy.cookies_enabled");function m(e){return!!(0,h.dV)().o.MO&&v(e)&&!0===(0,s.gD)(e,"session_trace.enabled")}var b=i(6389);class y extends f.W{constructor(e,t,r=!0){super(e.agentIdentifier,t),this.auto=r,this.abortHandler=void 0,this.featAggregate=void 0,this.onAggregateImported=void 0,!1===e.init[this.featureName].autoStart&&(this.auto=!1),this.auto?(0,l.Ak)(e.agentIdentifier,t):this.ee.on("manual-start-all",(0,b.J)((()=>{(0,l.Ak)(e.agentIdentifier,this.featureName),this.auto=!0,this.importAggregator(e)})))}importAggregator(t,r={}){if(this.featAggregate||!this.auto)return;let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let o;try{if(v(this.agentIdentifier)){const{setupAgentSession:e}=await i.e(296).then(i.bind(i,3861));o=e(t)}}catch(t){(0,e.R)(20,t),this.ee.emit("internal-error",[t]),this.featureName===a.K7.sessionReplay&&this.abortHandler?.()}try{if(t.sharedAggregator)await t.sharedAggregator;else{t.sharedAggregator=i.e(296).then(i.bind(i,9337));const{EventAggregator:e}=await t.sharedAggregator;t.sharedAggregator=new e}if(!this.#t(this.featureName,o))return(0,l.Ze)(this.agentIdentifier,this.featureName),void n(!1);const{lazyFeatureLoader:e}=await i.e(296).then(i.bind(i,6103)),{Aggregate:a}=await e(this.featureName,"aggregate");this.featAggregate=new a(t,r),n(!0)}catch(t){(0,e.R)(34,t),this.abortHandler?.(),(0,l.Ze)(this.agentIdentifier,this.featureName,!0),n(!1),this.ee&&this.ee.abort()}};p.RI?(0,g.GG)((()=>o()),!0):o()}#t(e,t){switch(e){case a.K7.sessionReplay:return m(this.agentIdentifier)&&!!t;case a.K7.sessionTrace:return!!t;default:return!0}}}var w=i(6630);class A extends y{static featureName=w.T;constructor(e,t=!0){super(e,w.T,t),this.importAggregator(e)}}var R=i(9908),E=i(2843),x=i(3878),_=i(782),N=i(1863);class T extends y{static featureName=_.T;constructor(e,t=!0){super(e,_.T,t),p.RI&&((0,E.u)((()=>(0,R.p)("docHidden",[(0,N.t)()],void 0,_.T,this.ee)),!0),(0,x.sp)("pagehide",(()=>(0,R.p)("winPagehide",[(0,N.t)()],void 0,_.T,this.ee))),this.importAggregator(e))}}var S=i(3969);class j extends y{static featureName=S.TZ;constructor(e,t=!0){super(e,S.TZ,t),this.importAggregator(e)}}new class extends o{constructor(t,r){super(r),p.gm?(this.features={},(0,h.bQ)(this.agentIdentifier,this),this.desiredFeatures=new Set(t.features||[]),this.desiredFeatures.add(A),this.runSoftNavOverSpa=[...this.desiredFeatures].some((e=>e.featureName===a.K7.softNav)),(0,d.j)(this,t,t.loaderType||"agent"),this.run()):(0,e.R)(21)}get config(){return{info:this.info,init:this.init,loader_config:this.loader_config,runtime:this.runtime}}run(){try{const t=u(this.agentIdentifier),r=[...this.desiredFeatures];r.sort(((e,t)=>a.P3[e.featureName]-a.P3[t.featureName])),r.forEach((r=>{if(!t[r.featureName]&&r.featureName!==a.K7.pageViewEvent)return;if(this.runSoftNavOverSpa&&r.featureName===a.K7.spa)return;if(!this.runSoftNavOverSpa&&r.featureName===a.K7.softNav)return;const n=function(e){switch(e){case a.K7.ajax:return[a.K7.jserrors];case a.K7.sessionTrace:return[a.K7.ajax,a.K7.pageViewEvent];case a.K7.sessionReplay:return[a.K7.sessionTrace];case a.K7.pageViewTiming:return[a.K7.pageViewEvent];default:return[]}}(r.featureName).filter((e=>!(e in this.features)));n.length>0&&(0,e.R)(36,{targetFeature:r.featureName,missingDependencies:n}),this.features[r.featureName]=new r(this)}))}catch(t){(0,e.R)(22,t);for(const e in this.features)this.features[e].abortHandler?.();const r=(0,h.Zm)();delete r.initializedAgents[this.agentIdentifier]?.api,delete r.initializedAgents[this.agentIdentifier]?.features,delete this.sharedAggregator;return r.ee.get(this.agentIdentifier).abort(),!1}}}({features:[A,T,j],loaderType:"lite"})})()})();</script> <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1"> <link rel="stylesheet" href="https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/bootstrap/bootstrap-grid-modal.min.css?ver=4.6.2" type="text/css"/> <link rel="stylesheet" href="https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/style.min.css?ver=1526505728" type="text/css"/> <link rel="stylesheet" href="https://endpts.com/wp-content/themes/endpoints-rakia/assets/css/fonts.min.css?ver=1526505728" type="text/css"/> <link rel="pingback" href="https://endpts.com/xmlrpc.php"> <link rel="apple-touch-icon" sizes="180x180" href="https://endpts.com/wp-content/themes/endpoints-rakia/assets/images/favicon/apple-touch-icon.png?v=OmJxx0N8zR"> <link rel="shortcut icon" href="/favicon.ico?v=OmJxx0N8zR" /> <link rel="icon" type="image/png" sizes="48x48" href="https://endpts.com/wp-content/themes/endpoints-rakia/assets/images/favicon/favicon-48x48.png?v=OmJxx0N8zR"> <link rel="icon" type="image/png" sizes="32x32" href="https://endpts.com/wp-content/themes/endpoints-rakia/assets/images/favicon/favicon-32x32.png?v=OmJxx0N8zR"> <link rel="icon" type="image/png" sizes="16x16" href="https://endpts.com/wp-content/themes/endpoints-rakia/assets/images/favicon/favicon-16x16.png?v=OmJxx0N8zR"> <link rel="icon" type="image/svg+xml" href="https://endpts.com/wp-content/themes/endpoints-rakia/assets/images/favicon/favicon.svg" /> <link rel="manifest" href="https://endpts.com/wp-content/themes/endpoints-rakia/assets/images/favicon/site.webmanifest?v=OmJxx0N8zR"> <link rel="mask-icon" href="https://endpts.com/wp-content/themes/endpoints-rakia/assets/images/favicon/safari-pinned-tab.svg?v=OmJxx0N8zR" color="#494949"> <link rel="shortcut icon" href="https://endpts.com/wp-content/themes/endpoints-rakia/assets/images/favicon/favicon.ico?v=OmJxx0N8zR"> <link rel="preload" href="https://endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/IvarText_Regular.woff2" as="font" crossorigin="anonymous"/> <link rel="preload" href="https://endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/IvarText_Bold.woff2" as="font" crossorigin="anonymous"/> <link rel="preload" href="https://endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/IvarText_Italic.woff2" as="font" crossorigin="anonymous"/> <link rel="preload" href="https://endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/IvarHeadline_SemiBold.woff2" as="font" crossorigin="anonymous"/> <link rel="preload" href="https://endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/Concourse_T4_Bold.woff2" as="font" crossorigin="anonymous"/> <link rel="preload" href="https://endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/Concourse_T4_Italic.woff2" as="font" crossorigin="anonymous"/> <link rel="preload" href="https://endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/Concourse_C4_Bold.woff2" as="font" crossorigin="anonymous"/> <link rel="preload" href="https://endpts.com/wp-content/themes/endpoints-rakia/assets/fonts/Concourse_C4_Regular.woff2" as="font" crossorigin="anonymous"/> <meta name="msapplication-TileColor" content="#bb9451"> <meta name="msapplication-config" content="https://endpts.com/wp-content/themes/endpoints-rakia/assets/images/favicon/browserconfig.xml?v=OmJxx0N8zR"> <meta name="theme-color" content="#ffffff"> <script type='text/javascript'> (function() { var _sf_async_config = window._sf_async_config = (window._sf_async_config || {}); _sf_async_config.uid = '67111'; _sf_async_config.domain = 'endpts.com'; _sf_async_config.useCanonical = true; _sf_async_config.useCanonicalDomain = true; _sf_async_config.type = 'Home Page'; var _cbq = window._cbq = (window._cbq || []); _cbq.push(['_acct', 'anon']); function loadChartbeat() { var e = document.createElement('script'); var n = document.getElementsByTagName('script')[0]; e.type = 'text/javascript'; e.async = true; e.src = '//static.chartbeat.com/js/chartbeat.js'; n.parentNode.insertBefore(e, n); } loadChartbeat(); })(); (function(w,d,s,c,u){ var qf=function(e,a){(w[c].q=w[c].q||[]).push([e,a]);};w[c]=w[c]||qf; var st=d.createElement(s); var fs=d.getElementsByTagName(s)[0]; st.async=1;st.src=u;fs.parentNode.insertBefore(st,fs); })(window,document,'script','chartbeat','https://static.chartbeat.com/js/subscriptions.js'); </script><title>Endpoints News – Biotech and pharma business news, with a focus on the science, people and money that drive the industry.</title> <meta name='robots' content='max-image-preview:large' /> <link rel='dns-prefetch' href='//www.googletagservices.com' /> <link rel='dns-prefetch' href='//api.stats.endpts.com' /> <link rel="alternate" type="application/rss+xml" title="Endpoints News » Feed" href="https://endpts.com/feed/" /> <script> window._wpemojiSettings = {"baseUrl":"https:\/\/s.w.org\/images\/core\/emoji\/15.0.3\/72x72\/","ext":".png","svgUrl":"https:\/\/s.w.org\/images\/core\/emoji\/15.0.3\/svg\/","svgExt":".svg","source":{"concatemoji":"https:\/\/endpts.com\/wp-includes\/js\/wp-emoji-release.min.js?ver=6.6.2"}}; /*! This file is auto-generated */ !function(i,n){var o,s,e;function c(e){try{var t={supportTests:e,timestamp:(new Date).valueOf()};sessionStorage.setItem(o,JSON.stringify(t))}catch(e){}}function p(e,t,n){e.clearRect(0,0,e.canvas.width,e.canvas.height),e.fillText(t,0,0);var t=new Uint32Array(e.getImageData(0,0,e.canvas.width,e.canvas.height).data),r=(e.clearRect(0,0,e.canvas.width,e.canvas.height),e.fillText(n,0,0),new Uint32Array(e.getImageData(0,0,e.canvas.width,e.canvas.height).data));return t.every(function(e,t){return e===r[t]})}function u(e,t,n){switch(t){case"flag":return n(e,"\ud83c\udff3\ufe0f\u200d\u26a7\ufe0f","\ud83c\udff3\ufe0f\u200b\u26a7\ufe0f")?!1:!n(e,"\ud83c\uddfa\ud83c\uddf3","\ud83c\uddfa\u200b\ud83c\uddf3")&&!n(e,"\ud83c\udff4\udb40\udc67\udb40\udc62\udb40\udc65\udb40\udc6e\udb40\udc67\udb40\udc7f","\ud83c\udff4\u200b\udb40\udc67\u200b\udb40\udc62\u200b\udb40\udc65\u200b\udb40\udc6e\u200b\udb40\udc67\u200b\udb40\udc7f");case"emoji":return!n(e,"\ud83d\udc26\u200d\u2b1b","\ud83d\udc26\u200b\u2b1b")}return!1}function f(e,t,n){var r="undefined"!=typeof WorkerGlobalScope&&self instanceof WorkerGlobalScope?new OffscreenCanvas(300,150):i.createElement("canvas"),a=r.getContext("2d",{willReadFrequently:!0}),o=(a.textBaseline="top",a.font="600 32px Arial",{});return e.forEach(function(e){o[e]=t(a,e,n)}),o}function t(e){var t=i.createElement("script");t.src=e,t.defer=!0,i.head.appendChild(t)}"undefined"!=typeof Promise&&(o="wpEmojiSettingsSupports",s=["flag","emoji"],n.supports={everything:!0,everythingExceptFlag:!0},e=new Promise(function(e){i.addEventListener("DOMContentLoaded",e,{once:!0})}),new Promise(function(t){var n=function(){try{var e=JSON.parse(sessionStorage.getItem(o));if("object"==typeof e&&"number"==typeof e.timestamp&&(new Date).valueOf()<e.timestamp+604800&&"object"==typeof e.supportTests)return e.supportTests}catch(e){}return null}();if(!n){if("undefined"!=typeof Worker&&"undefined"!=typeof OffscreenCanvas&&"undefined"!=typeof URL&&URL.createObjectURL&&"undefined"!=typeof Blob)try{var e="postMessage("+f.toString()+"("+[JSON.stringify(s),u.toString(),p.toString()].join(",")+"));",r=new Blob([e],{type:"text/javascript"}),a=new Worker(URL.createObjectURL(r),{name:"wpTestEmojiSupports"});return void(a.onmessage=function(e){c(n=e.data),a.terminate(),t(n)})}catch(e){}c(n=f(s,u,p))}t(n)}).then(function(e){for(var t in e)n.supports[t]=e[t],n.supports.everything=n.supports.everything&&n.supports[t],"flag"!==t&&(n.supports.everythingExceptFlag=n.supports.everythingExceptFlag&&n.supports[t]);n.supports.everythingExceptFlag=n.supports.everythingExceptFlag&&!n.supports.flag,n.DOMReady=!1,n.readyCallback=function(){n.DOMReady=!0}}).then(function(){return e}).then(function(){var e;n.supports.everything||(n.readyCallback(),(e=n.source||{}).concatemoji?t(e.concatemoji):e.wpemoji&&e.twemoji&&(t(e.twemoji),t(e.wpemoji)))}))}((window,document),window._wpemojiSettings); </script> <style id='wp-emoji-styles-inline-css'> img.wp-smiley, img.emoji { display: inline !important; border: none !important; box-shadow: none !important; height: 1em !important; width: 1em !important; margin: 0 0.07em !important; vertical-align: -0.1em !important; background: none !important; padding: 0 !important; } </style> <style id='classic-theme-styles-inline-css'> /*! This file is auto-generated */ .wp-block-button__link{color:#fff;background-color:#32373c;border-radius:9999px;box-shadow:none;text-decoration:none;padding:calc(.667em + 2px) calc(1.333em + 2px);font-size:1.125em}.wp-block-file__button{background:#32373c;color:#fff;text-decoration:none} </style> <style id='global-styles-inline-css'> :root{--wp--preset--aspect-ratio--square: 1;--wp--preset--aspect-ratio--4-3: 4/3;--wp--preset--aspect-ratio--3-4: 3/4;--wp--preset--aspect-ratio--3-2: 3/2;--wp--preset--aspect-ratio--2-3: 2/3;--wp--preset--aspect-ratio--16-9: 16/9;--wp--preset--aspect-ratio--9-16: 9/16;--wp--preset--color--black: #000000;--wp--preset--color--cyan-bluish-gray: #abb8c3;--wp--preset--color--white: #ffffff;--wp--preset--color--pale-pink: #f78da7;--wp--preset--color--vivid-red: #cf2e2e;--wp--preset--color--luminous-vivid-orange: #ff6900;--wp--preset--color--luminous-vivid-amber: #fcb900;--wp--preset--color--light-green-cyan: #7bdcb5;--wp--preset--color--vivid-green-cyan: #00d084;--wp--preset--color--pale-cyan-blue: #8ed1fc;--wp--preset--color--vivid-cyan-blue: #0693e3;--wp--preset--color--vivid-purple: #9b51e0;--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple: linear-gradient(135deg,rgba(6,147,227,1) 0%,rgb(155,81,224) 100%);--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan: linear-gradient(135deg,rgb(122,220,180) 0%,rgb(0,208,130) 100%);--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange: linear-gradient(135deg,rgba(252,185,0,1) 0%,rgba(255,105,0,1) 100%);--wp--preset--gradient--luminous-vivid-orange-to-vivid-red: linear-gradient(135deg,rgba(255,105,0,1) 0%,rgb(207,46,46) 100%);--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray: linear-gradient(135deg,rgb(238,238,238) 0%,rgb(169,184,195) 100%);--wp--preset--gradient--cool-to-warm-spectrum: linear-gradient(135deg,rgb(74,234,220) 0%,rgb(151,120,209) 20%,rgb(207,42,186) 40%,rgb(238,44,130) 60%,rgb(251,105,98) 80%,rgb(254,248,76) 100%);--wp--preset--gradient--blush-light-purple: linear-gradient(135deg,rgb(255,206,236) 0%,rgb(152,150,240) 100%);--wp--preset--gradient--blush-bordeaux: linear-gradient(135deg,rgb(254,205,165) 0%,rgb(254,45,45) 50%,rgb(107,0,62) 100%);--wp--preset--gradient--luminous-dusk: linear-gradient(135deg,rgb(255,203,112) 0%,rgb(199,81,192) 50%,rgb(65,88,208) 100%);--wp--preset--gradient--pale-ocean: linear-gradient(135deg,rgb(255,245,203) 0%,rgb(182,227,212) 50%,rgb(51,167,181) 100%);--wp--preset--gradient--electric-grass: linear-gradient(135deg,rgb(202,248,128) 0%,rgb(113,206,126) 100%);--wp--preset--gradient--midnight: linear-gradient(135deg,rgb(2,3,129) 0%,rgb(40,116,252) 100%);--wp--preset--font-size--small: 13px;--wp--preset--font-size--medium: 20px;--wp--preset--font-size--large: 36px;--wp--preset--font-size--x-large: 42px;--wp--preset--spacing--20: 0.44rem;--wp--preset--spacing--30: 0.67rem;--wp--preset--spacing--40: 1rem;--wp--preset--spacing--50: 1.5rem;--wp--preset--spacing--60: 2.25rem;--wp--preset--spacing--70: 3.38rem;--wp--preset--spacing--80: 5.06rem;--wp--preset--shadow--natural: 6px 6px 9px rgba(0, 0, 0, 0.2);--wp--preset--shadow--deep: 12px 12px 50px rgba(0, 0, 0, 0.4);--wp--preset--shadow--sharp: 6px 6px 0px rgba(0, 0, 0, 0.2);--wp--preset--shadow--outlined: 6px 6px 0px -3px rgba(255, 255, 255, 1), 6px 6px rgba(0, 0, 0, 1);--wp--preset--shadow--crisp: 6px 6px 0px rgba(0, 0, 0, 1);}:where(.is-layout-flex){gap: 0.5em;}:where(.is-layout-grid){gap: 0.5em;}body .is-layout-flex{display: flex;}.is-layout-flex{flex-wrap: wrap;align-items: center;}.is-layout-flex > :is(*, div){margin: 0;}body .is-layout-grid{display: grid;}.is-layout-grid > :is(*, div){margin: 0;}:where(.wp-block-columns.is-layout-flex){gap: 2em;}:where(.wp-block-columns.is-layout-grid){gap: 2em;}:where(.wp-block-post-template.is-layout-flex){gap: 1.25em;}:where(.wp-block-post-template.is-layout-grid){gap: 1.25em;}.has-black-color{color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-color{color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-color{color: var(--wp--preset--color--white) !important;}.has-pale-pink-color{color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-color{color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-color{color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-color{color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-color{color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-color{color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-color{color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-color{color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-color{color: var(--wp--preset--color--vivid-purple) !important;}.has-black-background-color{background-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-background-color{background-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-background-color{background-color: var(--wp--preset--color--white) !important;}.has-pale-pink-background-color{background-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-background-color{background-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-background-color{background-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-background-color{background-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-background-color{background-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-background-color{background-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-background-color{background-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-background-color{background-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-background-color{background-color: var(--wp--preset--color--vivid-purple) !important;}.has-black-border-color{border-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-border-color{border-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-border-color{border-color: var(--wp--preset--color--white) !important;}.has-pale-pink-border-color{border-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-border-color{border-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-border-color{border-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-border-color{border-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-border-color{border-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-border-color{border-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-border-color{border-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-border-color{border-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-border-color{border-color: var(--wp--preset--color--vivid-purple) !important;}.has-vivid-cyan-blue-to-vivid-purple-gradient-background{background: var(--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple) !important;}.has-light-green-cyan-to-vivid-green-cyan-gradient-background{background: var(--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan) !important;}.has-luminous-vivid-amber-to-luminous-vivid-orange-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange) !important;}.has-luminous-vivid-orange-to-vivid-red-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-orange-to-vivid-red) !important;}.has-very-light-gray-to-cyan-bluish-gray-gradient-background{background: var(--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray) !important;}.has-cool-to-warm-spectrum-gradient-background{background: var(--wp--preset--gradient--cool-to-warm-spectrum) !important;}.has-blush-light-purple-gradient-background{background: var(--wp--preset--gradient--blush-light-purple) !important;}.has-blush-bordeaux-gradient-background{background: var(--wp--preset--gradient--blush-bordeaux) !important;}.has-luminous-dusk-gradient-background{background: var(--wp--preset--gradient--luminous-dusk) !important;}.has-pale-ocean-gradient-background{background: var(--wp--preset--gradient--pale-ocean) !important;}.has-electric-grass-gradient-background{background: var(--wp--preset--gradient--electric-grass) !important;}.has-midnight-gradient-background{background: var(--wp--preset--gradient--midnight) !important;}.has-small-font-size{font-size: var(--wp--preset--font-size--small) !important;}.has-medium-font-size{font-size: var(--wp--preset--font-size--medium) !important;}.has-large-font-size{font-size: var(--wp--preset--font-size--large) !important;}.has-x-large-font-size{font-size: var(--wp--preset--font-size--x-large) !important;} :where(.wp-block-post-template.is-layout-flex){gap: 1.25em;}:where(.wp-block-post-template.is-layout-grid){gap: 1.25em;} :where(.wp-block-columns.is-layout-flex){gap: 2em;}:where(.wp-block-columns.is-layout-grid){gap: 2em;} :root :where(.wp-block-pullquote){font-size: 1.5em;line-height: 1.6;} </style> <link rel='stylesheet' id='EP_css-css' href='https://endpts.com/wp-content/plugins/endpoints/assets/css/endpoints.min.css?ver=2506754750' media='all' /> <link rel="EditURI" type="application/rsd+xml" title="RSD" href="https://endpts.com/xmlrpc.php?rsd" /> <meta name="keywords" content="Biotech and pharma business news, with a focus on the science, people and money that drive the industry." /><meta property="og:image" content="https://endpts.com/wp-content/plugins/endpoints/assets/images/preview_art_hp.jpg" /><meta property="twitter:image" content="https://endpts.com/wp-content/plugins/endpoints/assets/images/preview_art_hp.jpg" /><meta name="description" content="Biotech and pharma business news, with a focus on the science, people and money that drive the industry." /><meta property="og:description" content="Biotech and pharma business news, with a focus on the science, people and money that drive the industry." /><meta property="og:title" content="Endpoints News" /><meta property="og:url" content="https://endpts.com/" /><meta property="og:site_name" content="Endpoints News" /><meta property="og:type" content="website" /><meta property="article:section" content="Business & Health" /><meta name="twitter:card" content="summary_large_image"><meta name="twitter:site" content="@endpts"> <script async src="https://www.googletagmanager.com/gtag/js?id=G-9QWNX9N9E5"></script> <script> window.dataLayer = window.dataLayer || []; function gtag() { dataLayer.push(arguments); } gtag('js', new Date()); gtag('set', 'user_properties', { user_type: 'Guest', }); gtag('config', 'G-9QWNX9N9E5'); window._linkedin_data_partner_ids = window._linkedin_data_partner_ids || []; window._linkedin_data_partner_ids.push(2273916); window._linkedin_data_partner_ids.push(5136028); (function (l) { if (!l) { window.lintrk = function (a, b) { window.lintrk.q.push([a, b]) } window.lintrk.q = [] } var s = document.getElementsByTagName('script')[0] var b = document.createElement('script') b.type = 'text/javascript' b.async = true b.src = 'https://snap.licdn.com/li.lms-analytics/insight.min.js' s.parentNode.insertBefore(b, s) })(window.lintrk) </script> </head> <body class="home blog"> <header class="epn_header_menu"> <div class="container"> <div class="row"> <div class="col-6 col-md-2"> <a href="/" class="epn_logo"> <svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 288 22" style="enable-background:new 0 0 288 22;" xml:space="preserve"> <g> <path class="epn_svg_logo" d="M14.69,5.23H5.34v3.64h7.43v4.24H5.34v3.65h9.65v4.6H0V0.63h14.69V5.23z"></path> <path class="epn_svg_logo" d="M35.21,12.38h0.21V0.63h5.34v20.73h-3.41L26.18,9.58h-0.21v11.78h-5.34V0.63h3.41L35.21,12.38z"></path> <path class="epn_svg_logo" d="M46.8,21.37V0.63h7.35c6.12,0,10.92,4.15,10.92,10.39c0,6.61-4.56,10.35-10.88,10.35H46.8z M54.56,16.77 c2.91,0,5.05-2.14,5.05-5.83c0-3.57-2.79-5.71-5.09-5.71h-2.38v11.54H54.56z"></path> <path class="epn_svg_logo" d="M77.45,14.26h-2.13v7.1h-5.34V0.63h7.63c4.72,0,8.04,2.71,8.04,7.18C85.66,10.61,83.65,14.26,77.45,14.26z M77.04,5.03h-1.72v5.13h1.85c1.64,0,2.79-0.86,2.79-2.46C79.95,6.22,78.84,5.03,77.04,5.03z"></path> <path class="epn_svg_logo" d="M100.25,21.78c-6.49,0-11.12-4.68-11.12-10.67c0-6.61,5.34-10.88,11.12-10.88c5.66,0,11.04,4.15,11.04,10.88 C111.29,16.93,106.94,21.78,100.25,21.78z M100.21,4.9c-2.83,0-5.58,2.22-5.58,6.12c0,3.16,1.93,6.08,5.71,6.08 c3.04,0,5.5-2.26,5.5-6.08C105.83,7.37,103.25,4.9,100.21,4.9z"></path> <path class="epn_svg_logo" d="M121.84,21.37h-5.34V0.63h5.34V21.37z"></path> <path class="epn_svg_logo" d="M142.56,12.38h0.21V0.63h5.34v20.73h-3.41L133.53,9.58h-0.21v11.78h-5.34V0.63h3.41L142.56,12.38z"></path> <path class="epn_svg_logo" d="M163.91,5.23v16.13h-5.34V5.23h-6.24v-4.6h17.81v4.6H163.91z"></path> <path class="epn_svg_logo" d="M174.98,15.09c1.81,1.15,4.23,2.18,6.61,2.18c1.93,0,2.71-0.86,2.71-1.68c0-1.23-1.36-1.72-4.02-2.96 c-4.19-1.97-5.95-3.49-5.95-6.45s2.5-5.95,7.63-5.95c2.87,0,5.42,0.78,7.31,1.97l-1.23,4.27c-2.09-1.11-4.1-1.72-6.03-1.72 c-1.56,0-2.26,0.66-2.26,1.44c0,0.86,0.86,1.36,4.06,2.83c4.52,2.09,6.03,3.98,6.03,6.82c0,3.9-3.53,5.95-8.5,5.95 c-3.57,0-6.61-1.23-7.84-2.38L174.98,15.09z"></path> <path class="epn_svg_text" d="M214.24,18.33l0.12-0.08V0.84h1.64v20.53l-0.94,0.21L200.04,3.92l-0.12,0.04v17.41h-1.64V0.84l0.94-0.21 L214.24,18.33z"></path> <path class="epn_svg_text" d="M236.72,2.32h-11.45v7.84h10.22v1.48h-10.22v8.25h11.86v1.48h-13.5V0.84h13.09V2.32z"></path> <path class="st0" d="M255.6,4.99l-5.66,16.59h-0.41l-7.96-20.32l1.6-0.62l6.44,16.91h0.21l5.62-16.91h0.41l5.87,16.91h0.21 l6.16-16.91l1.64,0.62l-7.84,20.32h-0.41l-5.71-16.59H255.6z"></path> <path class="epn_svg_text" d="M274.13,17.84c1.56,1.4,3.94,2.42,6.69,2.42c3.94,0,5.46-1.85,5.46-3.86c0-2.14-1.72-3.53-5.38-4.97 c-4.93-1.89-6.69-3.33-6.69-5.95c0-2.5,2.18-5.05,6.36-5.05c2.87,0,5.58,1.35,6.98,2.67l-0.94,1.23c-1.72-1.4-3.53-2.38-6.03-2.38 c-3.08,0-4.64,1.6-4.64,3.41c0,1.93,1.15,2.87,5.62,4.64c4.76,1.89,6.44,3.78,6.44,6.36c0,2.92-2.18,5.42-7.22,5.42 c-3.32,0-6.36-1.31-7.59-2.63L274.13,17.84z"></path> </g> </svg> </a> </div> <div class="col-2 d-md-none"> <a href="#" class="epn_hamburger"><span></span><span></span><span></span></a> </div> <nav class="col-8 col-md epn_menu_container"> <div class="epn_menu"> <ul> <li class="menu-item-has-children"> <span>Channels</span> <ul> <li> <a href="/news/" title="See latest news">All News</a> </li> <li> <a href="https://endpts.com/channel/in-focus/" title="See Latest Stories in In Focus">In Focus</a> </li> <li> <a href="https://endpts.com/channel/special/" title="See Latest Stories in Special Channel">Special</a> </li> <li> <a href="https://endpts.com/channel/ai/" title="See Latest Stories in AI Channel">AI</a> </li> <li> <a href="https://endpts.com/channel/bioregnum/" title="See Latest Stories in Bioregnum Channel">Bioregnum</a> </li> <li> <a href="https://endpts.com/channel/biotech-voices/" title="See Latest Stories in Biotech Voices Channel">Biotech Voices</a> </li> <li> <a href="https://endpts.com/channel/cell-gene-tx/" title="See Latest Stories in Cell/Gene Tx Channel">Cell/Gene Tx</a> </li> <li> <a href="https://endpts.com/channel/china/" title="See Latest Stories in China Channel">China</a> </li> <li> <a href="https://endpts.com/channel/coronavirus/" title="See Latest Stories in Coronavirus Channel">Coronavirus</a> </li> <li> <a href="https://endpts.com/channel/deals/" title="See Latest Stories in Deals Channel">Deals</a> </li> <li> <a href="https://endpts.com/channel/diagnostics/" title="See Latest Stories in Diagnostics Channel">Diagnostics</a> </li> <li> <a href="https://endpts.com/channel/discovery/" title="See Latest Stories in Discovery Channel">Discovery</a> </li> <li> <a href="https://endpts.com/channel/fda-plus/" title="See Latest Stories in FDA+ Channel">FDA+</a> </li> <li> <a href="https://endpts.com/channel/financing/" title="See Latest Stories in Financing Channel">Financing</a> </li> <li> <a href="https://endpts.com/channel/health-tech/" title="See Latest Stories in Health Tech Channel">Health Tech</a> </li> <li> <a href="https://endpts.com/channel/law/" title="See Latest Stories in Law Channel">Law</a> </li> <li> <a href="https://endpts.com/channel/letters-to-the-editor/" title="See Latest Stories in Letters to the Editor Channel">Letters to the Editor</a> </li> <li> <a href="https://endpts.com/channel/manufacturing/" title="See Latest Stories in Manufacturing Channel">Manufacturing</a> </li> <li> <a href="https://endpts.com/channel/marketing/" title="See Latest Stories in Marketing Channel">Marketing</a> </li> <li> <a href="https://endpts.com/channel/nikkei-biotechnology/" title="See Latest Stories in Nikkei Biotechnology Channel">Nikkei Biotechnology</a> </li> <li> <a href="https://endpts.com/channel/opinion/" title="See Latest Stories in Opinion Channel">Opinion</a> </li> <li> <a href="https://endpts.com/channel/outsourcing/" title="See Latest Stories in Outsourcing Channel">Outsourcing</a> </li> <li> <a href="https://endpts.com/channel/peer-review/" title="See Latest Stories in Peer Review Channel">Peer Review</a> </li> <li> <a href="https://endpts.com/channel/people/" title="See Latest Stories in People Channel">People</a> </li> <li> <a href="https://endpts.com/channel/pharma/" title="See Latest Stories in Pharma Channel">Pharma</a> </li> <li> <a href="https://endpts.com/channel/rd/" title="See Latest Stories in R&D Channel">R&D</a> </li> <li> <a href="https://endpts.com/channel/startups/" title="See Latest Stories in Startups Channel">Startups</a> </li> <li> <a href="https://endpts.com/channel/weekly/" title="See Latest Stories in Weekly Channel">Weekly</a> </li> </ul> </li> <li> <a href="https://webinars.endpts.com" title="Endpoints Webinars" target="_blank">Webinars</a> </li> <li> <a href="https://careers.endpts.com" title="Endpoints Careers" target="_blank">Biopharma Jobs</a> </li> <li class="menu-item-has-children"> <span>More</span> <ul> <li><a href="https://ats.rippling.com/endpointsnews/jobs/" rel="nofollow noopener" target="_blank" title="Work at Endpoints">Work at Endpoints</a></li> <li><a href="https://endpts.com/letter-to-editors/" target="_blank" title="Letter to Editors">Letter to Editors</a></li> <li><a href="https://endpts.com/editorial-standards/" target="_blank" title="Editorial Standards">Editorial Standards</a></li> <li><a href="https://endpts.com/ipo-tracker/" target="_blank" title="Endpoints News IPO Tracker">IPO Tracker</a></li> <li><a href="https://webinars.endpts.com/" target="_blank" title="Endpoints Webinars">Webinars</a></li> <li><a href="https://endpoints.studio/events/" title="Endpoints Events" target="_blank">Events</a></li> <li><a href="https://endpts.com/sponsored/" title="See all Sponsored Posts">Sponsored Posts</a></li> <li><a href="https://endpoints.studio" target="_blank" title="Endpoints Studio">Advertise</a></li> <li><a href="https://www.iubenda.com/privacy-policy/286978" rel="nofollow noopener" target="_blank">Privacy Policy</a></li> <li><a href="https://store.endpts.com" target="_blank">Endpoints Merch</a></li> <li><a href="https://endpts.com/about-endpoints-news/" title="About Endpoints News">About Us</a></li> <li><span data-intercom-open >Help</span></li> </ul> </li> </ul> <div class="epn_search_bar"> <form action="https://endpts.com/"> <input type="text" name="s" placeholder="Search"> <button class="epn_ux_button epn_white epn_search_submit_button"></button> </form> <button class="epn_ux_button epn_white epn_search_button"></button> </div> </div> </nav> <div class="col-8 col-md-2 epn_profile"> <div class="epn_user epn_logged_out"> <ul> <li><a href="https://endpts.com/subscribe/" class="epn_navigation_sign_up_button" title="Subscribe to Endpoints News">SIGN UP</a></li> <li> <button data-toggle="modal" class="epn_navigation_log_in_button" data-target="#epn_sign_in_modal">LOG IN</button> </li> </ul> </div> </div> </div> </div> </header><section class="epn_ad_wrapper epn_regular_section epn_ads_full_width"><div class="container"><div class="row"><div class="col-8"><div id="rakia_above_tiles" data-slot="/21729248569/rakia_banner_above_tiles_homepage"></div></div></div></div></section><section class="epn_regular_section epn_home_featured"> <div class="container"> <div class="row"> <div class="col-8 col-md-4"> <h3 class="epn_section_title">top stories</h3> <div class="epn_white_box epn_article_box epn_featured epn_big"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2021/02/epn_weekly_tile.jpg');"> <a href="https://endpts.com/trump-announces-picks-for-fda-cdc-novartis-seeks-bolt-on-deals-raises-guidance-rfk-jr-elon-musk-may-find-banning-ads-difficult-and-more/" title="Trump announces picks for FDA, CDC; Novartis seeks bolt-on deals, raises guidance; RFK Jr., Elon Musk may find banning ads difficult; and more"></a> </div> <div class="epn_text"> <div class="epn_title"> <h1 class="epn_headline epn_big"> <a href="https://endpts.com/trump-announces-picks-for-fda-cdc-novartis-seeks-bolt-on-deals-raises-guidance-rfk-jr-elon-musk-may-find-banning-ads-difficult-and-more/" title="Trump announces picks for FDA, CDC; Novartis seeks bolt-on deals, raises guidance; RFK Jr., Elon Musk may find banning ads difficult; and more">Trump announces picks for FDA, CDC; Novartis seeks bolt-on deals, raises guidance; RFK Jr., Elon Musk may find banning ads difficult; and more</a> </h1> </div> <div class="epn_byline"> <div class="epn_time">5 hours ago</div> <div class="epn_channel channel-weekly"><a href="https://endpts.com/channel/weekly/" title="Channel: Weekly"><span>Weekly</span></a></div> </div> </div> </div> <div class="epn_ad_wrapper ep_sponsored_container"><div class="epn_article_ad" id="rakia_sponsored_front_page" data-slot="/21729248569/rakia_sponsored_front_page"></div></div> </div> <div class="col-8 col-md-2 epn_headless"> <div class="epn_white_box epn_article_box epn_featured"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2023/05/CDC-headquarters-AP-tile.jpg');"> <a href="https://endpts.com/trump-picks-former-congressman-and-vaccine-injury-advocate-to-lead-cdc/" title="For CDC, Trump picks Dave Weldon, a former congressman who pushed for vaccine injury claims"></a> </div> <div class="epn_text"> <div class="epn_title"> <h1 class="epn_headline"> <a href="https://endpts.com/trump-picks-former-congressman-and-vaccine-injury-advocate-to-lead-cdc/" title="For CDC, Trump picks Dave Weldon, a former congressman who pushed for vaccine injury claims">For CDC, Trump picks Dave Weldon, a former congressman who pushed for vaccine injury claims</a> </h1> </div> <div class="epn_byline"> <div class="epn_time">13 hours ago</div> <div class="epn_channel channel-people"><a href="https://endpts.com/channel/people/" title="Channel: People"><span>People</span></a></div><div class="epn_channel channel-pharma"><a href="https://endpts.com/channel/pharma/" title="Channel: Pharma"><span>Pharma</span></a></div> </div> </div> </div><div class="epn_white_box epn_article_box epn_featured"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2024/11/Marty-Makary-Getty-tile.jpg');"> <a href="https://endpts.com/trump-picks-hopkins-researcher-marty-makary-to-lead-the-fda/" title="Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks"></a> </div> <div class="epn_text"> <div class="epn_title"> <h1 class="epn_headline"> <a href="https://endpts.com/trump-picks-hopkins-researcher-marty-makary-to-lead-the-fda/" title="Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks">Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks</a> </h1> </div> <div class="epn_byline"> <div class="epn_time">15 hours ago</div> <div class="epn_channel channel-people"><a href="https://endpts.com/channel/people/" title="Channel: People"><span>People</span></a></div><div class="epn_channel channel-fda-plus"><a href="https://endpts.com/channel/fda-plus/" title="Channel: FDA+"><span>FDA+</span></a></div> </div> </div> </div><div class="epn_white_box epn_article_box epn_featured"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2023/02/FDA-headquarters-Getty-tile.jpg');"> <a href="https://endpts.com/fda-approves-bridgebios-heart-disease-drug-setting-up-competition-with-pfizer-alnylam/" title="FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam"></a> </div> <div class="epn_text"> <div class="epn_title"> <h1 class="epn_headline"> <a href="https://endpts.com/fda-approves-bridgebios-heart-disease-drug-setting-up-competition-with-pfizer-alnylam/" title="FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam">FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam</a> </h1> </div> <div class="epn_byline"> <div class="epn_time">16 hours ago</div> <div class="epn_channel channel-pharma"><a href="https://endpts.com/channel/pharma/" title="Channel: Pharma"><span>Pharma</span></a></div><div class="epn_channel channel-fda-plus"><a href="https://endpts.com/channel/fda-plus/" title="Channel: FDA+"><span>FDA+</span></a></div> </div> </div> </div> </div> <div class="col-8 col-md-2"> <h3 class="epn_section_title">Latest</h3> <div class="epn_white_box epn_stream_box epn_stream_block"> <div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/sanofi-introduces-new-340b-payment-model-report/" title="Sanofi introduces new 340B payment model — report">Sanofi introduces new 340B payment model — report</a> </h3> <div class="epn_byline"> <div class="epn_time">20 hours ago</div> <div class="epn_channel channel-pharma"><a href="https://endpts.com/channel/pharma/" title="Channel: Pharma"><span>Pharma</span></a></div><div class="epn_channel channel-law"><a href="https://endpts.com/channel/law/" title="Channel: Law"><span>Law</span></a></div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/drug-or-biologic-an-eli-lilly-lawsuit-could-impact-weight-loss-drug-compounders/" title="Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders">Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders</a> </h3> <div class="epn_byline"> <div class="epn_time">20 hours ago</div> <div class="epn_channel channel-pharma"><a href="https://endpts.com/channel/pharma/" title="Channel: Pharma"><span>Pharma</span></a></div><div class="epn_channel channel-law"><a href="https://endpts.com/channel/law/" title="Channel: Law"><span>Law</span></a></div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/senate-committee-advances-pharma-patent-challenge-bill/" title="Senate Judiciary Committee advances patent bill with new protections for pharma challenges">Senate Judiciary Committee advances patent bill with new protections for pharma challenges</a> </h3> <div class="epn_byline"> <div class="epn_time">23 hours ago</div> <div class="epn_channel channel-pharma"><a href="https://endpts.com/channel/pharma/" title="Channel: Pharma"><span>Pharma</span></a></div><div class="epn_channel channel-law"><a href="https://endpts.com/channel/law/" title="Channel: Law"><span>Law</span></a></div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/from-vaccines-to-psychedelics-five-drugmakers-on-what-could-change-under-a-trump-administration/" title="From vaccines to psychedelics, five drugmakers on what could change under a Trump administration">From vaccines to psychedelics, five drugmakers on what could change under a Trump administration</a> </h3> <div class="epn_byline"> <div class="epn_time">Yesterday</div> <div class="epn_channel channel-pharma"><a href="https://endpts.com/channel/pharma/" title="Channel: Pharma"><span>Pharma</span></a></div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/halozyme-withdraws-e2b-evotec-acquisition-proposal/" title="Halozyme withdraws Evotec acquisition proposal after biotech is 'unwilling to engage'">Halozyme withdraws Evotec acquisition proposal after biotech is 'unwilling to engage'</a> </h3> <div class="epn_byline"> <div class="epn_time">Yesterday</div> <div class="epn_channel channel-deals"><a href="https://endpts.com/channel/deals/" title="Channel: Deals"><span>Deals</span></a></div><div class="epn_channel channel-pharma"><a href="https://endpts.com/channel/pharma/" title="Channel: Pharma"><span>Pharma</span></a></div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/lexicon-ends-commercial-work-to-focus-on-rd/" title="Lexicon ends commercial work to focus on R&D">Lexicon ends commercial work to focus on R&D</a> </h3> <div class="epn_byline"> <div class="epn_time">Yesterday</div> <div class="epn_channel channel-people"><a href="https://endpts.com/channel/people/" title="Channel: People"><span>People</span></a></div><div class="epn_channel channel-pharma"><a href="https://endpts.com/channel/pharma/" title="Channel: Pharma"><span>Pharma</span></a></div> </div> </div> <div class="epn_more"> <a href="https://endpts.com/news/" title="See Latest Stream">see latest stream</a> </div> </div> </div> </div> </div> </section><section class="epn_regular_section epn_home_categories_feed"> <div class="container"> <div class="row"> <div class="col-8 col-md-2"> <div class="epn_stream_box epn_white_box channel-people epn_color_top"> <div class="epn_section_title channel-people"> <span><a href="https://endpts.com/channel/people/" title="Channel: People">People</a></span> </div> <div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/amgen-names-geneticist-and-biotech-founder-to-chief-science-role/" title="Amgen names Stanford geneticist and biotech founder to CSO post">Amgen names Stanford geneticist and biotech founder to CSO post</a> </h3> <div class="epn_byline"> <div class="epn_time">2 days ago</div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/pfizer-taps-oncology-head-boshoff-as-dolstens-chief-scientific-officer-successor/" title="Pfizer taps oncology head Boshoff as Dolsten's chief scientific officer successor">Pfizer taps oncology head Boshoff as Dolsten's chief scientific officer successor</a> </h3> <div class="epn_byline"> <div class="epn_time">3 days ago</div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/exclusive-former-pfizer-commercial-chief-angela-hwang-to-join-flagship/" title="Exclusive: Former Pfizer commercial chief Angela Hwang to join Flagship">Exclusive: Former Pfizer commercial chief Angela Hwang to join Flagship</a> </h3> <div class="epn_byline"> <div class="epn_time">3 days ago</div> </div> </div> </div> </div><div class="col-8 col-md-2"> <div class="epn_stream_box epn_white_box channel-financing epn_color_top"> <div class="epn_section_title channel-financing"> <span><a href="https://endpts.com/channel/financing/" title="Channel: Financing">Financing</a></span> </div> <div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/enveda-raises-130m-for-drugs-in-ii-obesity-and-other-areas/" title="Microsoft-backed Enveda raises $130M for drugs in I&I, obesity and other areas">Microsoft-backed Enveda raises $130M for drugs in I&I, obesity and other areas</a> </h3> <div class="epn_byline"> <div class="epn_time">Yesterday</div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/venrock-adds-500m-to-healthcare-investing-strategy-after-outlining-10th-fund-in-january/" title="Venrock adds $500M to healthcare investing strategy after outlining 10th fund in January">Venrock adds $500M to healthcare investing strategy after outlining 10th fund in January</a> </h3> <div class="epn_byline"> <div class="epn_time">2 days ago</div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/carolyn-bertozzis-new-biotech-debuts-with-30m-for-immunotherapy-work/" title="Carolyn Bertozzi’s latest biotech debuts with $30M seed round and a sugary spin on immunotherapy">Carolyn Bertozzi’s latest biotech debuts with $30M seed round and a sugary spin on immunotherapy</a> </h3> <div class="epn_byline"> <div class="epn_time">3 days ago</div> </div> </div> </div> </div><div class="col-8 col-md-2"> <div class="epn_stream_box epn_white_box channel-startups epn_color_top"> <div class="epn_section_title channel-startups"> <span><a href="https://endpts.com/channel/startups/" title="Channel: Startups">Startups</a></span> </div> <div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/pfizer-partners-with-two-more-flagship-biotechs-on-obesity-cancer/" title="Pfizer partners with two more Flagship biotechs on obesity, cancer">Pfizer partners with two more Flagship biotechs on obesity, cancer</a> </h3> <div class="epn_byline"> <div class="epn_time">3 days ago</div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/jupiter-bioventures-raises-70m-fund-for-super-early-science/" title="Former NCI director teams up with serial entrepreneur for $70M VC fund targeting 'super-early' science">Former NCI director teams up with serial entrepreneur for $70M VC fund targeting 'super-early' science</a> </h3> <div class="epn_byline"> <div class="epn_time">4 days ago</div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/atlas-venture-targets-450m-for-14th-biotech-venture-fund/" title="Atlas Venture targets $450M for 14th biotech fund, the same size as its 2022 raise">Atlas Venture targets $450M for 14th biotech fund, the same size as its 2022 raise</a> </h3> <div class="epn_byline"> <div class="epn_time">5 days ago</div> </div> </div> </div> </div><div class="col-8 col-md-2"> <div class="epn_stream_box epn_white_box channel-deals epn_color_top"> <div class="epn_section_title channel-deals"> <span><a href="https://endpts.com/channel/deals/" title="Channel: Deals">Deals</a></span> </div> <div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/novartis-buys-kate-therapeutics-in-1-1b-deal-eyes-more-bolt-on-ma/" title="Novartis seeks more bolt-on deals as it purchases neuro startup for up to $1.1B">Novartis seeks more bolt-on deals as it purchases neuro startup for up to $1.1B</a> </h3> <div class="epn_byline"> <div class="epn_time">2 days ago</div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/kyowa-kirin-buys-into-kura-leukemia-treatment-rights-for-330m/" title="Kyowa Kirin acquires ex-US rights to Kura’s leukemia treatment for $330M upfront">Kyowa Kirin acquires ex-US rights to Kura’s leukemia treatment for $330M upfront</a> </h3> <div class="epn_byline"> <div class="epn_time">2 days ago</div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/23andme-inks-new-research-partnership-as-it-winds-down-internal-drug-development-efforts/" title="23andMe inks new research partnership as it winds down internal drug development efforts">23andMe inks new research partnership as it winds down internal drug development efforts</a> </h3> <div class="epn_byline"> <div class="epn_time">3 days ago</div> </div> </div> </div> </div> </div> </div> </section><section class="epn_homepage_cta"> <div class="container"> <div class="row"> <div class="col-8 col-md-4"> <div class="epn_logo"> <img loading="lazy" src="https://endpts.com/wp-content/themes/endpoints-rakia/assets/svg/epn-logo-tagline-negative.svg" alt="Endpoints News"> </div> <div class="epn_text"> <p>All of the news, delivered with full-text to your inbox. For professionals discovering, developing, and marketing biopharmaceutical drugs.</p> <a href="https://endpts.com/subscribe/" title="Subscribe to Endpoints News" class="epn_cta_button">SIGN UP NOW</a> </div> </div> <div class="col-8 col-md-4"> <div class="epn_cta_illustration" style="background-image: url('https://endpts.com/wp-content/themes/endpoints-rakia/assets/images/epn_basic_globe@x2.png');"> <img srcset="https://endpts.com/wp-content/themes/endpoints-rakia/assets/images/epn_basic_devices.png, https://endpts.com/wp-content/themes/endpoints-rakia/assets/images/epn_basic_devices@x2.png 2x" src="https://endpts.com/wp-content/themes/endpoints-rakia/assets/images/epn_basic_devices@x2.png" alt="Subscribe to Endpoints News"> </div> </div> </div> </div> </section><section class="epn_regular_section epn_homepage_stories"> <div class="container"> <div class="row"> <div class="col-8"> <h3 class="epn_section_title"> <span>In Focus</span><a href="https://endpts.com/channel/in-focus/" title="See all stories">See all</a> </h3> </div> </div> <div class="row"> <div class="col-8 col-md-2"> <div class="epn_white_box epn_article_box epn_story"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2024/11/Telehealth-shutterstock-tile.jpg');"> <a href="https://endpts.com/pharma-telehealth-programs-are-catching-on-and-raising-questions/" title="Lawmakers are poking holes in pharma's favorite new way to market medicines"></a> </div> <div class="epn_text"> <div class="epn_title"> <h1 class="epn_headline"><a href="https://endpts.com/pharma-telehealth-programs-are-catching-on-and-raising-questions/" title="Lawmakers are poking holes in pharma's favorite new way to market medicines">Lawmakers are poking holes in pharma's favorite new way to market medicines</a></h1> </div> <div class="epn_byline"> <div class="epn_time">4 days ago</div> <div class="epn_channel channel-pharma"><a href="https://endpts.com/channel/pharma/" title="Channel: Pharma"><span>Pharma</span></a></div><div class="epn_channel channel-health-tech"><a href="https://endpts.com/channel/health-tech/" title="Channel: Health Tech"><span>Health Tech</span></a></div> </div> </div> </div> </div><div class="col-8 col-md-2"> <div class="epn_white_box epn_article_box epn_story"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2024/11/shutterstock_242439133-scaled.jpg');"> <a href="https://endpts.com/a-rare-neurological-disease-is-sages-last-best-hope-after-failures-in-depression/" title="A rare neurological disease is Sage’s last, best hope after failures in depression"></a> </div> <div class="epn_text"> <div class="epn_title"> <h1 class="epn_headline"><a href="https://endpts.com/a-rare-neurological-disease-is-sages-last-best-hope-after-failures-in-depression/" title="A rare neurological disease is Sage’s last, best hope after failures in depression">A rare neurological disease is Sage’s last, best hope after failures in depression</a></h1> </div> <div class="epn_byline"> <div class="epn_time">5 days ago</div> <div class="epn_channel channel-rd"><a href="https://endpts.com/channel/rd/" title="Channel: R&D"><span>R&D</span></a></div><div class="epn_channel channel-pharma"><a href="https://endpts.com/channel/pharma/" title="Channel: Pharma"><span>Pharma</span></a></div> </div> </div> </div> </div><div class="col-8 col-md-2"> <div class="epn_white_box epn_article_box epn_story"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2024/10/parathyroid-hormone-shutterstock-tile.jpg');"> <a href="https://endpts.com/yorvipaths-approval-showcases-biopharmas-interest-in-rare-endocrine-disorder/" title="Yorvipath’s approval showcases biopharma’s interest in rare endocrine disorder"></a> </div> <div class="epn_text"> <div class="epn_title"> <h1 class="epn_headline"><a href="https://endpts.com/yorvipaths-approval-showcases-biopharmas-interest-in-rare-endocrine-disorder/" title="Yorvipath’s approval showcases biopharma’s interest in rare endocrine disorder">Yorvipath’s approval showcases biopharma’s interest in rare endocrine disorder</a></h1> </div> <div class="epn_byline"> <div class="epn_time">Last week</div> <div class="epn_channel channel-startups"><a href="https://endpts.com/channel/startups/" title="Channel: Startups"><span>Startups</span></a></div><div class="epn_channel channel-rd"><a href="https://endpts.com/channel/rd/" title="Channel: R&D"><span>R&D</span></a></div> </div> </div> </div> </div><div class="col-8 col-md-2"> <div class="epn_white_box epn_article_box epn_story"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2024/11/Casey-Means-HLTH24-social1.jpg');"> <a href="https://endpts.com/biotech-industry-worries-over-potential-for-rfk-jr-ally-as-fda-pick/" title="Biotech industry worries over potential for RFK Jr. ally as FDA pick"></a> </div> <div class="epn_text"> <div class="epn_title"> <h1 class="epn_headline"><a href="https://endpts.com/biotech-industry-worries-over-potential-for-rfk-jr-ally-as-fda-pick/" title="Biotech industry worries over potential for RFK Jr. ally as FDA pick">Biotech industry worries over potential for RFK Jr. ally as FDA pick</a></h1> </div> <div class="epn_byline"> <div class="epn_time">3 weeks ago</div> <div class="epn_channel channel-fda-plus"><a href="https://endpts.com/channel/fda-plus/" title="Channel: FDA+"><span>FDA+</span></a></div> </div> </div> </div> </div> </div> </div> </section><section class="epn_regular_section epn_homepage_stories"> <div class="container"> <div class="row"> <div class="col-8"> <h3 class="epn_section_title"> <span>Endpoints Standouts</span> </h3> </div> </div> <div class="row"> <div class="col-8 col-md-2"> <div class="epn_white_box epn_article_box epn_story"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2024/07/the_best_paying_tile.jpg');"> <a href="https://endpts.com/how-the-worlds-biggest-pharma-and-biotech-companies-paid-their-typical-worker-in-2023/" title="How the world's biggest pharma and biotech companies paid their typical worker in 2023"></a> </div> <div class="epn_text"> <div class="epn_title"> <h1 class="epn_headline"><a href="https://endpts.com/how-the-worlds-biggest-pharma-and-biotech-companies-paid-their-typical-worker-in-2023/" title="How the world's biggest pharma and biotech companies paid their typical worker in 2023">How the world's biggest pharma and biotech companies paid their typical worker in 2023</a></h1> </div> <div class="epn_byline"> <div class="epn_time">4 months ago</div> <div class="epn_channel channel-people"><a href="https://endpts.com/channel/people/" title="Channel: People"><span>People</span></a></div><div class="epn_channel channel-pharma"><a href="https://endpts.com/channel/pharma/" title="Channel: Pharma"><span>Pharma</span></a></div> </div> </div> </div> </div><div class="col-8 col-md-2"> <div class="epn_white_box epn_article_box epn_story"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2024/01/money-cash-financing-shutterstock-tile.jpg');"> <a href="https://endpts.com/in-biotechs-uneven-recovery-50-startups-raised-megarounds-in-first-half-of-2024/" title="In biotech's uneven recovery, 50 startups raised megarounds in first half of 2024"></a> </div> <div class="epn_text"> <div class="epn_title"> <h1 class="epn_headline"><a href="https://endpts.com/in-biotechs-uneven-recovery-50-startups-raised-megarounds-in-first-half-of-2024/" title="In biotech's uneven recovery, 50 startups raised megarounds in first half of 2024">In biotech's uneven recovery, 50 startups raised megarounds in first half of 2024</a></h1> </div> <div class="epn_byline"> <div class="epn_time">4 months ago</div> <div class="epn_channel channel-financing"><a href="https://endpts.com/channel/financing/" title="Channel: Financing"><span>Financing</span></a></div><div class="epn_channel channel-startups"><a href="https://endpts.com/channel/startups/" title="Channel: Startups"><span>Startups</span></a></div> </div> </div> </div> </div><div class="col-8 col-md-2"> <div class="epn_white_box epn_article_box epn_story"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2024/06/LGBTQ_tile.jpg');"> <a href="https://endpts.com/biopharma-leaders-charting-a-path-for-the-industrys-lgbtq-community/" title="Biopharma leaders charting a path for the industry's LGBTQ+ community"></a> </div> <div class="epn_text"> <div class="epn_title"> <h1 class="epn_headline"><a href="https://endpts.com/biopharma-leaders-charting-a-path-for-the-industrys-lgbtq-community/" title="Biopharma leaders charting a path for the industry's LGBTQ+ community">Biopharma leaders charting a path for the industry's LGBTQ+ community</a></h1> </div> <div class="epn_byline"> <div class="epn_time">5 months ago</div> <div class="epn_channel channel-people"><a href="https://endpts.com/channel/people/" title="Channel: People"><span>People</span></a></div><div class="epn_channel channel-special"><a href="https://endpts.com/channel/special/" title="Channel: Special"><span>Special</span></a></div> </div> </div> </div> </div><div class="col-8 col-md-2"> <div class="epn_white_box epn_article_box epn_story"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2021/04/Peter-Marks-tile-AP-scaled.jpg');"> <a href="https://endpts.com/fdas-peter-marks-single-handedly-approved-sareptas-gene-therapy-what-does-that-mean-for-everyone-else/" title="Peter Marks single-handedly approved Sarepta’s gene therapy — what does that mean for everyone else?"></a> </div> <div class="epn_text"> <div class="epn_title"> <h1 class="epn_headline"><a href="https://endpts.com/fdas-peter-marks-single-handedly-approved-sareptas-gene-therapy-what-does-that-mean-for-everyone-else/" title="Peter Marks single-handedly approved Sarepta’s gene therapy — what does that mean for everyone else?">Peter Marks single-handedly approved Sarepta’s gene therapy — what does that mean for everyone else?</a></h1> </div> <div class="epn_byline"> <div class="epn_time">5 months ago</div> <div class="epn_channel channel-pharma"><a href="https://endpts.com/channel/pharma/" title="Channel: Pharma"><span>Pharma</span></a></div><div class="epn_channel channel-cell-gene-tx"><a href="https://endpts.com/channel/cell-gene-tx/" title="Channel: Cell/Gene Tx"><span>Cell/Gene Tx</span></a></div> </div> </div> </div> </div> </div> </div> </section><section class="epn_regular_section epn_homepage_category_feed_calendar"> <div class="container"> <div class="row"> <div class="col-8 epn_heading"> <h3 class="epn_section_title channel-peer-review"><span>Peer review</span> <a href="https://endpts.com/channel/peer-review/" title="See all Peer Review Stories">See all</a></h3> </div> </div> <div class="row"> <div class="col-8 col-md-4"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/themes/endpoints-rakia/assets/images/epn_peer_review_image@x2.jpg');"></div> </div> <div class="col-8 col-md-4"> <div class="epn_feed_holder epn_white_box"> <div class="epn_item"> <div class="epn_date"> <div class="epn_header"> <span>Nov</span> </div> <span>22</span> </div> <div class="epn_text"> <h3><a href="https://endpts.com/lillys-board-undergoes-more-changes-merck-strategy-chief-joins-roger-perlmutter-at-eikon/" title="Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon">Lilly's board undergoes more changes; Merck strategy chief joins Roger Perlmutter at Eikon</a></h3> </div> </div><div class="epn_item"> <div class="epn_date"> <div class="epn_header"> <span>Nov</span> </div> <span>15</span> </div> <div class="epn_text"> <h3><a href="https://endpts.com/alx-oncology-hires-genentech-mirati-vet-as-new-cmo-after-carmot-heather-turner-has-three-new-roles-on-tap/" title="ALX Oncology hires Genentech, Mirati vet as CMO; After Carmot, Heather Turner has three new roles on tap">ALX Oncology hires Genentech, Mirati vet as CMO; After Carmot, Heather Turner has three new roles on tap</a></h3> </div> </div><div class="epn_item"> <div class="epn_date"> <div class="epn_header"> <span>Nov</span> </div> <span>8</span> </div> <div class="epn_text"> <h3><a href="https://endpts.com/legend-names-a-president-of-carvykti-novo-nordisks-top-north-america-exec-is-stepping-down/" title="Legend names a president of Carvykti; Novo Nordisk's top North America exec is stepping down">Legend names a president of Carvykti; Novo Nordisk's top North America exec is stepping down</a></h3> </div> </div><div class="epn_item"> <div class="epn_date"> <div class="epn_header"> <span>Nov</span> </div> <span>1</span> </div> <div class="epn_text"> <h3><a href="https://endpts.com/biogen-brings-in-medical-chief-as-cfo-plans-retirement-macrogenics-ceo-announces-departure/" title="Biogen brings in medical chief as CFO plans retirement; MacroGenics CEO announces departure">Biogen brings in medical chief as CFO plans retirement; MacroGenics CEO announces departure</a></h3> </div> </div><div class="epn_item"> <div class="epn_date"> <div class="epn_header"> <span>Oct</span> </div> <span>25</span> </div> <div class="epn_text"> <h3><a href="https://endpts.com/chinook-alums-reunite-following-exit-to-novartis-the-first-board-appointment-for-recursions-chris-gibson/" title="Chinook alums reunite following exit to Novartis; The first board appointment for Recursion’s Chris Gibson">Chinook alums reunite following exit to Novartis; The first board appointment for Recursion’s Chris Gibson</a></h3> </div> </div> </div> </div> </div> </div> </section><section class="epn_regular_section epn_homepage_category_feed channel-pharma"> <div class="container"> <div class="row"> <div class="col-8 epn_heading"> <h3 class="epn_section_title"> <span>Pharma channel feed</span></h3> </div> </div> <div class="row"> <div class="col-8 col-md-3"> <div class="epn_white_box epn_article_box epn_featured epn_big"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2024/01/Vas-Narasimhan-Novartis-Getty-tile1.jpg');"> <a href="https://endpts.com/with-yearslong-reorganization-behind-it-novartis-increases-its-sales-guidance/" title="With yearslong reorganization behind it, Novartis increases its sales guidance"></a> </div> <div class="epn_text"> <div class="epn_date"> <span>Yesterday</span> </div> <div class="epn_title"> <h1 class="epn_headline epn_big"><a href="https://endpts.com/with-yearslong-reorganization-behind-it-novartis-increases-its-sales-guidance/" title="With yearslong reorganization behind it, Novartis increases its sales guidance">With yearslong reorganization behind it, Novartis increases its sales guidance</a></h1> </div> <div class="epn_text_block"> <p>Novartis’ reorganization is paying off, CEO Vas Narasimhan told investors at an event Thursday in London. </p> <a href="https://endpts.com/with-yearslong-reorganization-behind-it-novartis-increases-its-sales-guidance/" title="With yearslong reorganization behind it, Novartis increases its sales guidance" class="epn_ux_button epn_more">READ MORE</a> </div> </div> </div> </div> <div class="col-8 col-md-2"> <div class="epn_white_box epn_article_box epn_featured"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2020/12/Jazz-Pharmaceuticals-tile-shutterstock-scaled.jpg');"> <a href="https://endpts.com/jazz-wins-approval-for-bispecific-in-biliary-tract-cancer/" title="Jazz wins approval for bispecific in biliary tract cancer"></a> </div> <div class="epn_text"> <div class="epn_title"> <h1 class="epn_headline"><a href="https://endpts.com/jazz-wins-approval-for-bispecific-in-biliary-tract-cancer/" title="Jazz wins approval for bispecific in biliary tract cancer">Jazz wins approval for bispecific in biliary tract cancer</a></h1> </div> <div class="epn_byline"> <div class="epn_time">Yesterday</div> <div class="epn_channel channel-fda-plus"><a href="https://endpts.com/channel/fda-plus/" title="Channel: FDA+"><span>FDA+</span></a></div> </div> </div> </div><div class="epn_white_box epn_article_box epn_featured"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2024/11/Peter-Marks-Jefferies-London-tile.jpg');"> <a href="https://endpts.com/fda-vaccine-chief-peter-marks-pledges-to-stay-as-long-as-hes-welcome/" title="FDA vaccine chief Peter Marks pledges to stay as long as he's welcome"></a> </div> <div class="epn_text"> <div class="epn_title"> <h1 class="epn_headline"><a href="https://endpts.com/fda-vaccine-chief-peter-marks-pledges-to-stay-as-long-as-hes-welcome/" title="FDA vaccine chief Peter Marks pledges to stay as long as he's welcome">FDA vaccine chief Peter Marks pledges to stay as long as he's welcome</a></h1> </div> <div class="epn_byline"> <div class="epn_time">2 days ago</div> </div> </div> </div> </div> <div class="col-8 col-md-3"> <div class="epn_stream_box epn_white_box epn_use_more channel-pharma"> <div class="epn_badge">latest in Pharma</div> <div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/newamsterdam-aces-phase-3-trial-but-investors-are-skeptical/" title="NewAmsterdam aces Phase 3 trial, but investors are skeptical">NewAmsterdam aces Phase 3 trial, but investors are skeptical</a> </h3> <div class="epn_byline"> <div class="epn_time">2 days ago</div> <div class="epn_channel channel-rd"><a href="https://endpts.com/channel/rd/" title="Channel: R&D"><span>R&D</span></a></div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/fda-updates-label-of-33-year-old-cancer-drug-with-new-dose-and-warning/" title="FDA updates label of 33-year-old cancer drug with new dose and warning">FDA updates label of 33-year-old cancer drug with new dose and warning</a> </h3> <div class="epn_byline"> <div class="epn_time">2 days ago</div> <div class="epn_channel channel-fda-plus"><a href="https://endpts.com/channel/fda-plus/" title="Channel: FDA+"><span>FDA+</span></a></div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/gsk-plots-regulatory-filings-for-pbc-itch-after-positive-phase-3-readout/" title="GSK plots regulatory filings for PBC itch after positive Phase 3 readout">GSK plots regulatory filings for PBC itch after positive Phase 3 readout</a> </h3> <div class="epn_byline"> <div class="epn_time">3 days ago</div> <div class="epn_channel channel-fda-plus"><a href="https://endpts.com/channel/fda-plus/" title="Channel: FDA+"><span>FDA+</span></a></div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/nice-has-done-all-we-can-to-negotiate-for-enhertu-coverage/" title="NICE has 'done all we can' to negotiate for Enhertu coverage, reaffirms decision not to recommend">NICE has 'done all we can' to negotiate for Enhertu coverage, reaffirms decision not to recommend</a> </h3> <div class="epn_byline"> <div class="epn_time">3 days ago</div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/fda-rejects-astellas-effort-to-support-longer-use-of-izervay/" title="FDA rejects Astellas’ effort to support longer use of eye drug Izervay ">FDA rejects Astellas’ effort to support longer use of eye drug Izervay </a> </h3> <div class="epn_byline"> <div class="epn_time">3 days ago</div> <div class="epn_channel channel-fda-plus"><a href="https://endpts.com/channel/fda-plus/" title="Channel: FDA+"><span>FDA+</span></a></div> </div> </div> <div class="epn_more"> <a href="https://endpts.com/channel/pharma/" title="See Latest Stories in Pharma Channel">see latest stories</a> </div> </div> </div> </div> </div> </section><section class="epn_regular_section epn_homepage_category_feed channel-marketing"> <div class="container"> <div class="row"> <div class="col-8 epn_heading"> <h3 class="epn_section_title"> <span>Marketing channel feed</span></h3> </div> </div> <div class="row"> <div class="col-8 col-md-3"> <div class="epn_white_box epn_article_box epn_featured epn_big"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2024/11/Ozempic-DTC-pharma-ad-YouTube-tile.jpg');"> <a href="https://endpts.com/could-trump-and-rfk-jr-ban-drug-ads-past-efforts-have-largely-failed/" title="RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try"></a> </div> <div class="epn_text"> <div class="epn_date"> <span>Yesterday</span> </div> <div class="epn_title"> <h1 class="epn_headline epn_big"><a href="https://endpts.com/could-trump-and-rfk-jr-ban-drug-ads-past-efforts-have-largely-failed/" title="RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try">RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try</a></h1> </div> <div class="epn_text_block"> <p>As the healthcare priorities of President-elect Donald Trump and his HHS pick Robert F. Kennedy Jr. take shape, one idea gaining steam is a ban on direct-to-consumer pharmaceutical ... </p> <a href="https://endpts.com/could-trump-and-rfk-jr-ban-drug-ads-past-efforts-have-largely-failed/" title="RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try" class="epn_ux_button epn_more">READ MORE</a> </div> </div> </div> </div> <div class="col-8 col-md-2"> <div class="epn_white_box epn_article_box epn_featured"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2024/11/Nate-Berkus-AP-tile1.jpg');"> <a href="https://endpts.com/fda-says-merzs-social-media-promotion-with-nate-berkus-is-misleading/" title="FDA says Merz's social media promotion with Nate Berkus is 'misleading'"></a> </div> <div class="epn_text"> <div class="epn_title"> <h1 class="epn_headline"><a href="https://endpts.com/fda-says-merzs-social-media-promotion-with-nate-berkus-is-misleading/" title="FDA says Merz's social media promotion with Nate Berkus is 'misleading'">FDA says Merz's social media promotion with Nate Berkus is 'misleading'</a></h1> </div> <div class="epn_byline"> <div class="epn_time">Last week</div> <div class="epn_channel channel-pharma"><a href="https://endpts.com/channel/pharma/" title="Channel: Pharma"><span>Pharma</span></a></div> </div> </div> </div><div class="epn_white_box epn_article_box epn_featured"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2023/03/Lyme-disease-tick-shutterstock.jpg');"> <a href="https://endpts.com/valneva-and-pfizer-eye-2027-launch-for-partnered-lyme-disease-vaccine/" title="Valneva and Pfizer eye 2027 launch for partnered Lyme disease vaccine"></a> </div> <div class="epn_text"> <div class="epn_title"> <h1 class="epn_headline"><a href="https://endpts.com/valneva-and-pfizer-eye-2027-launch-for-partnered-lyme-disease-vaccine/" title="Valneva and Pfizer eye 2027 launch for partnered Lyme disease vaccine">Valneva and Pfizer eye 2027 launch for partnered Lyme disease vaccine</a></h1> </div> <div class="epn_byline"> <div class="epn_time">Last month</div> <div class="epn_channel channel-pharma"><a href="https://endpts.com/channel/pharma/" title="Channel: Pharma"><span>Pharma</span></a></div> </div> </div> </div> </div> <div class="col-8 col-md-3"> <div class="epn_stream_box epn_white_box epn_use_more channel-marketing"> <div class="epn_badge">latest in Marketing</div> <div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/uk-watchdog-criticizes-moderna-for-covid-19-trials-use-of-whatsapp-to-dangle-payments-to-children/" title="UK watchdog criticizes Moderna for Covid-19 trial's use of WhatsApp to dangle payments to children">UK watchdog criticizes Moderna for Covid-19 trial's use of WhatsApp to dangle payments to children</a> </h3> <div class="epn_byline"> <div class="epn_time">Last month</div> <div class="epn_channel channel-pharma"><a href="https://endpts.com/channel/pharma/" title="Channel: Pharma"><span>Pharma</span></a></div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/fda-criticizes-abbvies-misleading-ad-with-serena-williams/" title="FDA criticizes AbbVie's 'misleading' ad with Serena Williams">FDA criticizes AbbVie's 'misleading' ad with Serena Williams</a> </h3> <div class="epn_byline"> <div class="epn_time">2 months ago</div> <div class="epn_channel channel-pharma"><a href="https://endpts.com/channel/pharma/" title="Channel: Pharma"><span>Pharma</span></a></div><div class="epn_channel channel-fda-plus"><a href="https://endpts.com/channel/fda-plus/" title="Channel: FDA+"><span>FDA+</span></a></div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/madrigal-finally-reveals-first-wave-of-sales-for-mash-drug-rezdiffra/" title="Updated: Madrigal finally reveals first wave of sales for MASH drug Rezdiffra">Updated: Madrigal finally reveals first wave of sales for MASH drug Rezdiffra</a> </h3> <div class="epn_byline"> <div class="epn_time">3 months ago</div> <div class="epn_channel channel-pharma"><a href="https://endpts.com/channel/pharma/" title="Channel: Pharma"><span>Pharma</span></a></div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/rsv-market-pressure-leads-to-slower-launch-for-modernas-vaccine/" title="RSV market pressure leads to slower launch for Moderna's vaccine">RSV market pressure leads to slower launch for Moderna's vaccine</a> </h3> <div class="epn_byline"> <div class="epn_time">3 months ago</div> <div class="epn_channel channel-pharma"><a href="https://endpts.com/channel/pharma/" title="Channel: Pharma"><span>Pharma</span></a></div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/verona-inks-financing-deal-worth-up-to-650m-ahead-of-copd-decision/" title="Verona inks financing deal worth up to $650M ahead of COPD decision">Verona inks financing deal worth up to $650M ahead of COPD decision</a> </h3> <div class="epn_byline"> <div class="epn_time">6 months ago</div> <div class="epn_channel channel-financing"><a href="https://endpts.com/channel/financing/" title="Channel: Financing"><span>Financing</span></a></div> </div> </div> <div class="epn_more"> <a href="https://endpts.com/channel/marketing/" title="See Latest Stories in Marketing Channel">see latest stories</a> </div> </div> </div> </div> </div> </section><section class="epn_regular_section epn_homepage_category_feed channel-fda-plus"> <div class="container"> <div class="row"> <div class="col-8 epn_heading"> <h3 class="epn_section_title"> <span>FDA+ channel feed</span></h3> </div> </div> <div class="row"> <div class="col-8 col-md-3"> <div class="epn_white_box epn_article_box epn_featured epn_big"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2024/06/FDA-shutterstock-tile2.jpg');"> <a href="https://endpts.com/fda-adcomm-raises-risk-questions-on-astrazenecas-andexxa/" title="FDA adcomm raises risk questions on AstraZeneca’s Andexxa"></a> </div> <div class="epn_text"> <div class="epn_date"> <span>Yesterday</span> </div> <div class="epn_title"> <h1 class="epn_headline epn_big"><a href="https://endpts.com/fda-adcomm-raises-risk-questions-on-astrazenecas-andexxa/" title="FDA adcomm raises risk questions on AstraZeneca’s Andexxa">FDA adcomm raises risk questions on AstraZeneca’s Andexxa</a></h1> </div> <div class="epn_text_block"> <p>Members of an FDA advisory committee were not asked to vote Thursday on AstraZeneca’s anticoagulant reversal drug Andexxa, but they did raise several safety and efficacy concerns. </p> <a href="https://endpts.com/fda-adcomm-raises-risk-questions-on-astrazenecas-andexxa/" title="FDA adcomm raises risk questions on AstraZeneca’s Andexxa" class="epn_ux_button epn_more">READ MORE</a> </div> </div> </div> </div> <div class="col-8 col-md-2"> <div class="epn_white_box epn_article_box epn_featured"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2024/05/rob-califf-ap-tile.jpg');"> <a href="https://endpts.com/when-generative-ai-meets-the-fda-first-digital-health-adcomm-kicks-off-discussion/" title="When generative AI meets the FDA: First digital health adcomm kicks off discussion"></a> </div> <div class="epn_text"> <div class="epn_title"> <h1 class="epn_headline"><a href="https://endpts.com/when-generative-ai-meets-the-fda-first-digital-health-adcomm-kicks-off-discussion/" title="When generative AI meets the FDA: First digital health adcomm kicks off discussion">When generative AI meets the FDA: First digital health adcomm kicks off discussion</a></h1> </div> <div class="epn_byline"> <div class="epn_time">2 days ago</div> <div class="epn_channel channel-ai"><a href="https://endpts.com/channel/ai/" title="Channel: AI"><span>AI</span></a></div><div class="epn_channel channel-health-tech"><a href="https://endpts.com/channel/health-tech/" title="Channel: Health Tech"><span>Health Tech</span></a></div> </div> </div> </div><div class="epn_white_box epn_article_box epn_featured"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2024/06/AstraZeneca-AP-tile.jpg');"> <a href="https://endpts.com/fda-raises-safety-questions-on-astrazenecas-bleeding-reversal-agent/" title="Ahead of adcomm, FDA raises safety questions for AstraZeneca’s reversal agent for life-threatening bleeds"></a> </div> <div class="epn_text"> <div class="epn_title"> <h1 class="epn_headline"><a href="https://endpts.com/fda-raises-safety-questions-on-astrazenecas-bleeding-reversal-agent/" title="Ahead of adcomm, FDA raises safety questions for AstraZeneca’s reversal agent for life-threatening bleeds">Ahead of adcomm, FDA raises safety questions for AstraZeneca’s reversal agent for life-threatening bleeds</a></h1> </div> <div class="epn_byline"> <div class="epn_time">3 days ago</div> <div class="epn_channel channel-pharma"><a href="https://endpts.com/channel/pharma/" title="Channel: Pharma"><span>Pharma</span></a></div> </div> </div> </div> </div> <div class="col-8 col-md-3"> <div class="epn_stream_box epn_white_box epn_use_more channel-fda-plus"> <div class="epn_badge">latest in FDA+</div> <div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/chinese-drugmaker-receives-fda-warning-letter-after-management-hindered-inspection/" title="Chinese drugmaker receives FDA warning letter after management hindered inspection">Chinese drugmaker receives FDA warning letter after management hindered inspection</a> </h3> <div class="epn_byline"> <div class="epn_time">3 days ago</div> <div class="epn_channel channel-manufacturing"><a href="https://endpts.com/channel/manufacturing/" title="Channel: Manufacturing"><span>Manufacturing</span></a></div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/syndaxs-revuforj-wins-fda-approval-in-aggressive-form-of-leukemia/" title="Syndax's Revuforj wins FDA approval in aggressive form of leukemia">Syndax's Revuforj wins FDA approval in aggressive form of leukemia</a> </h3> <div class="epn_byline"> <div class="epn_time">4 days ago</div> <div class="epn_channel channel-pharma"><a href="https://endpts.com/channel/pharma/" title="Channel: Pharma"><span>Pharma</span></a></div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/fda-offers-more-guidance-on-developing-cell-and-gene-therapies/" title="FDA offers more guidance on developing cell and gene therapies">FDA offers more guidance on developing cell and gene therapies</a> </h3> <div class="epn_byline"> <div class="epn_time">4 days ago</div> <div class="epn_channel channel-cell-gene-tx"><a href="https://endpts.com/channel/cell-gene-tx/" title="Channel: Cell/Gene Tx"><span>Cell/Gene Tx</span></a></div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/what-is-the-future-of-the-trump-admins-pharmaceutical-policies/" title="Post-Hoc: RFK vs. Vivek, and the future of US drug policy">Post-Hoc: RFK vs. Vivek, and the future of US drug policy</a> </h3> <div class="epn_byline"> <div class="epn_time">Last week</div> <div class="epn_channel channel-editors-note"><a href="https://endpts.com/channel/editors-note/" title="Channel: Editor's note"><span>Editor's note</span></a></div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/lilly-sues-us-government-over-proposed-340b-rebate-model/" title="Eli Lilly sues the US government over its proposed 340B rebate model">Eli Lilly sues the US government over its proposed 340B rebate model</a> </h3> <div class="epn_byline"> <div class="epn_time">Last week</div> <div class="epn_channel channel-pharma"><a href="https://endpts.com/channel/pharma/" title="Channel: Pharma"><span>Pharma</span></a></div><div class="epn_channel channel-law"><a href="https://endpts.com/channel/law/" title="Channel: Law"><span>Law</span></a></div> </div> </div> <div class="epn_more"> <a href="https://endpts.com/channel/fda-plus/" title="See Latest Stories in FDA+ Channel">see latest stories</a> </div> </div> </div> </div> </div> </section><section class="epn_regular_section epn_homepage_category_feed channel-manufacturing"> <div class="container"> <div class="row"> <div class="col-8 epn_heading"> <h3 class="epn_section_title"> <span>Manufacturing channel feed</span></h3> </div> </div> <div class="row"> <div class="col-8 col-md-3"> <div class="epn_white_box epn_article_box epn_featured epn_big"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2024/11/jefferies-healthcare-conference-london-feature.jpg');"> <a href="https://endpts.com/at-jefferies-all-that-manufacturers-want-to-talk-about-is-glp-1s/" title="At Jefferies, all that manufacturers want to talk about is GLP-1s"></a> </div> <div class="epn_text"> <div class="epn_date"> <span>Yesterday</span> </div> <div class="epn_title"> <h1 class="epn_headline epn_big"><a href="https://endpts.com/at-jefferies-all-that-manufacturers-want-to-talk-about-is-glp-1s/" title="At Jefferies, all that manufacturers want to talk about is GLP-1s">At Jefferies, all that manufacturers want to talk about is GLP-1s</a></h1> </div> <div class="epn_text_block"> <p>LONDON — Thousands of delegates flooded into the narrow corridors of the Waldorf Hilton this week to attend the Jefferies London Healthcare Conference. It was so busy that at one point, ... </p> <a href="https://endpts.com/at-jefferies-all-that-manufacturers-want-to-talk-about-is-glp-1s/" title="At Jefferies, all that manufacturers want to talk about is GLP-1s" class="epn_ux_button epn_more">READ MORE</a> </div> </div> </div> </div> <div class="col-8 col-md-2"> <div class="epn_white_box epn_article_box epn_featured"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2021/02/mf-tile.jpg');"> <a href="https://endpts.com/samsung-bios-new-668m-client-sanofi-expands-a-factory-in-france/" title="Samsung Bio's new $668M client; Sanofi expands a factory in France"></a> </div> <div class="epn_text"> <div class="epn_title"> <h1 class="epn_headline"><a href="https://endpts.com/samsung-bios-new-668m-client-sanofi-expands-a-factory-in-france/" title="Samsung Bio's new $668M client; Sanofi expands a factory in France">Samsung Bio's new $668M client; Sanofi expands a factory in France</a></h1> </div> <div class="epn_byline"> <div class="epn_time">2 days ago</div> </div> </div> </div><div class="epn_white_box epn_article_box epn_featured"> <div class="epn_image" style="background-image: url('https://endpts.com/wp-content/uploads/2024/11/Christian-Wojczewski-and-Helen-Torley.jpg');"> <a href="https://endpts.com/evotec-gains-on-halozymes-takeover-proposal/" title="Evotec gains on Halozyme's takeover proposal"></a> </div> <div class="epn_text"> <div class="epn_title"> <h1 class="epn_headline"><a href="https://endpts.com/evotec-gains-on-halozymes-takeover-proposal/" title="Evotec gains on Halozyme's takeover proposal">Evotec gains on Halozyme's takeover proposal</a></h1> </div> <div class="epn_byline"> <div class="epn_time">Last week</div> <div class="epn_channel channel-deals"><a href="https://endpts.com/channel/deals/" title="Channel: Deals"><span>Deals</span></a></div> </div> </div> </div> </div> <div class="col-8 col-md-3"> <div class="epn_stream_box epn_white_box epn_use_more channel-manufacturing"> <div class="epn_badge">latest in Manufacturing</div> <div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/european-commission-seeks-biopharma-feedback-on-novo-catalent-deal-report/" title="European Commission seeks biopharma feedback on Novo-Catalent deal — report">European Commission seeks biopharma feedback on Novo-Catalent deal — report</a> </h3> <div class="epn_byline"> <div class="epn_time">Last week</div> <div class="epn_channel channel-deals"><a href="https://endpts.com/channel/deals/" title="Channel: Deals"><span>Deals</span></a></div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/lonza-expands-bioconjugates-factory-wuxi-bio-adds-capacity-in-germany/" title="Lonza expands bioconjugates factory; WuXi Bio adds capacity in Germany ">Lonza expands bioconjugates factory; WuXi Bio adds capacity in Germany </a> </h3> <div class="epn_byline"> <div class="epn_time">Last week</div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/novo-nordisk-to-phase-out-its-production-of-human-insulin-pens-globally/" title="Novo Nordisk to phase out its production of human insulin pens globally">Novo Nordisk to phase out its production of human insulin pens globally</a> </h3> <div class="epn_byline"> <div class="epn_time">Last week</div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/merck-kgaas-life-science-unit-is-still-feeling-the-covid-demand-decline/" title="Merck KGaA’s life science unit is still feeling the Covid demand decline">Merck KGaA’s life science unit is still feeling the Covid demand decline</a> </h3> <div class="epn_byline"> <div class="epn_time">Last week</div> <div class="epn_channel channel-pharma"><a href="https://endpts.com/channel/pharma/" title="Channel: Pharma"><span>Pharma</span></a></div> </div> </div><div class="epn_item"> <h3 class="epn_headline"> <a href="https://endpts.com/fda-drug-inspections-have-fallen-from-2016-peak-gao-says/" title="Drug inspector attrition leads to 'many fewer' checks than 2016 peak, GAO says">Drug inspector attrition leads to 'many fewer' checks than 2016 peak, GAO says</a> </h3> <div class="epn_byline"> <div class="epn_time">Last week</div> <div class="epn_channel channel-fda-plus"><a href="https://endpts.com/channel/fda-plus/" title="Channel: FDA+"><span>FDA+</span></a></div> </div> </div> <div class="epn_more"> <a href="https://endpts.com/channel/manufacturing/" title="See Latest Stories in Manufacturing Channel">see latest stories</a> </div> </div> </div> </div> </div> </section><footer class="epn_footer"> <div class="container"> <div class="row"> <div class="col-8 col-md-2"> <a href="/" class="epn_logo"> <img loading="lazy" src="https://endpts.com/wp-content/themes/endpoints-rakia/assets/svg/epn-logo-tagline-negative.svg" alt="Endpoints News"> </a> <div class="epn_info"> <p>Bioscience & Technology Business Center<br>The University of Kansas<br>Lawrence, Kansas </p> </div> <div class="epn_social"> <a href="https://twitter.com/endpts" rel="nofollow noopener" target="_blank" class="epn_footer_twitter" title="Endpoints on Twitter"></a> <a href="https://www.linkedin.com/company/endpoints" rel="nofollow noopener" target="_blank" class="epn_footer_linkedin" title="Endpoints on LinkedIn"></a> </div> </div> <nav class="col-8 col-md-1"> <h3>Latest</h3> <ul> <li><a href="https://endpts.com/news/" title="Latest news">All News</a></li> <li><a href="https://endpts.com/channel/special/" title="Special stories">Special</a></li> <li><a href="https://endpts.com/channel/in-focus/" title="In Focus stories">In Focus</a></li>  </ul> </nav> <nav class="col-8 col-md-2"> <h3>Channels</h3> <ul class="epn_menu_2_columns"> <li> <a href="https://endpts.com/channel/ai/" title="See Latest Stories in AI Channel">AI</a> </li> <li> <a href="https://endpts.com/channel/bioregnum/" title="See Latest Stories in Bioregnum Channel">Bioregnum</a> </li> <li> <a href="https://endpts.com/channel/biotech-voices/" title="See Latest Stories in Biotech Voices Channel">Biotech Voices</a> </li> <li> <a href="https://endpts.com/channel/cell-gene-tx/" title="See Latest Stories in Cell/Gene Tx Channel">Cell/Gene Tx</a> </li> <li> <a href="https://endpts.com/channel/china/" title="See Latest Stories in China Channel">China</a> </li> <li> <a href="https://endpts.com/channel/coronavirus/" title="See Latest Stories in Coronavirus Channel">Coronavirus</a> </li> <li> <a href="https://endpts.com/channel/deals/" title="See Latest Stories in Deals Channel">Deals</a> </li> <li> <a href="https://endpts.com/channel/diagnostics/" title="See Latest Stories in Diagnostics Channel">Diagnostics</a> </li> <li> <a href="https://endpts.com/channel/discovery/" title="See Latest Stories in Discovery Channel">Discovery</a> </li> <li> <a href="https://endpts.com/channel/fda-plus/" title="See Latest Stories in FDA+ Channel">FDA+</a> </li> <li> <a href="https://endpts.com/channel/financing/" title="See Latest Stories in Financing Channel">Financing</a> </li> <li> <a href="https://endpts.com/channel/health-tech/" title="See Latest Stories in Health Tech Channel">Health Tech</a> </li> <li> <a href="https://endpts.com/channel/law/" title="See Latest Stories in Law Channel">Law</a> </li> <li> <a href="https://endpts.com/channel/letters-to-the-editor/" title="See Latest Stories in Letters to the Editor Channel">Letters to the Editor</a> </li> <li> <a href="https://endpts.com/channel/manufacturing/" title="See Latest Stories in Manufacturing Channel">Manufacturing</a> </li> <li> <a href="https://endpts.com/channel/marketing/" title="See Latest Stories in Marketing Channel">Marketing</a> </li> <li> <a href="https://endpts.com/channel/nikkei-biotechnology/" title="See Latest Stories in Nikkei Biotechnology Channel">Nikkei Biotechnology</a> </li> <li> <a href="https://endpts.com/channel/opinion/" title="See Latest Stories in Opinion Channel">Opinion</a> </li> <li> <a href="https://endpts.com/channel/outsourcing/" title="See Latest Stories in Outsourcing Channel">Outsourcing</a> </li> <li> <a href="https://endpts.com/channel/peer-review/" title="See Latest Stories in Peer Review Channel">Peer Review</a> </li> <li> <a href="https://endpts.com/channel/people/" title="See Latest Stories in People Channel">People</a> </li> <li> <a href="https://endpts.com/channel/pharma/" title="See Latest Stories in Pharma Channel">Pharma</a> </li> <li> <a href="https://endpts.com/channel/rd/" title="See Latest Stories in R&D Channel">R&D</a> </li> <li> <a href="https://endpts.com/channel/startups/" title="See Latest Stories in Startups Channel">Startups</a> </li> <li> <a href="https://endpts.com/channel/weekly/" title="See Latest Stories in Weekly Channel">Weekly</a> </li> </ul> </nav> <nav class="col-8 col-md-1"> <h3>More</h3> <ul> <li> <a href="https://ats.rippling.com/endpointsnews/jobs" rel="nofollow noopener" target="_blank" title="Work at Endpoints">Work at Endpoints</a> </li> <li> <a href="https://endpts.com/letter-to-editors/" target="_blank" title="Letter to Editors">Letter to Editors</a> </li> <li> <a href="https://endpts.com/editorial-standards/" target="_blank" title="Editorial Standards">Editorial Standards</a> </li> <li> <a href="https://endpts.com/ipo-tracker/" target="_blank" title="Endpoints News IPO Tracker">IPO Tracker</a> </li> <li> <a href="https://endpoints.studio/events/" target="_blank" title="Endpoints Events">Events</a> </li> <li><a href="https://webinars.endpts.com/" target="_blank" title="Endpoints Webinars">Webinars</a> </li> <li> <a href="https://endpts.com/sponsored/" title="See all Sponsored Posts">Sponsored Posts</a> </li> <li> <a href="https://endpoints.studio" target="_blank" title="Endpoints Studio">Advertise</a> </li> <li> <a href="https://store.endpts.com" target="_blank">Endpoints Merch</a> </li> <li> <a href="https://endpts.com/about-endpoints-news/" title="About Endpoints News">About Us</a> </li> <li> <span data-intercom-open >Help</span> </li> </ul> </nav> <nav class="col-8 col-md-2"> <h3>Work in biotech</h3> <ul> <li><a href="https://careers.endpts.com" title="Endpoints Careers">Endpoints Careers</a></li> </ul> </nav> </div> <div class="row epn_copyright"> <div class="col-8 col-md-4"> <p>© Endpoints News 2024</p> </div> <nav class="col-8 col-md-4"> <ul> <li> <span data-intercom-open >Help</span> </li> <li> <a href="https://mediakit.endpts.com" target="_blank">Advertise</a> </li> <li> <a href="https://www.iubenda.com/privacy-policy/286978" rel="nofollow noopener" target="_blank">Privacy Policy</a> </li> <li> <a href="https://endpts.com/from-the-founders-endpoints-is-now-part-of-the-financial-times-family/">Business Model</a> </li> </ul> </nav> </div> </div> </footer> <div class="container-fluid"> <div class="ft-spec-footer row align-items-center"> <div class="col-3 col-md-4"> <a href="https://www.ftspecialist.com/index.html" target="_blank" rel="noopener noreferrer"> <img class="ft-spec-logo" src="https://endpts.com/wp-content/themes/endpoints-rakia/assets/svg/ft/ft_specialist.svg" alt="FT Specialist Logo"> </a> </div> <div class="col-5 col-md-4 ft-spec-service"> <img src="https://endpts.com/wp-content/themes/endpoints-rakia/assets/svg/ft/ft_service.svg" alt="A service from the Financial Times"> </div> </div> </div> <div class="modal epn_form epn_hidden_soft" tabindex="-1" role="dialog" id="epn_sign_in_modal" aria-hidden="true"> <div class="modal-dialog modal-dialog-centered" role="document"> <div class="modal-content"> <div class="epn_overlay epn_hidden_soft"> <div class="epn_loader_spinner epn_solid_gold epn_inside_overlay"></div> </div> <div class="modal-header"> <img src="https://endpts.com/wp-content/themes/endpoints-rakia/assets/svg/epn_logo.svg" alt="Endpoints News"> <button class="epn_form_close" data-dismiss="modal"></button> </div> <div class="modal-body"> <div class="container-fluid"> <div class="row"> <div class="col-8"> <fieldset class="epn_form_content"> <h3 class="epn_ux_modal_caption"> <span class="epn_golden">Log in to your account</span> </h3> <h3 class="epn_ux_modal_caption"> <span class="epn_svg ux_envelope"></span> <span>email</span> </h3> <div class="epn_ux_input epn_no_grey_background"> <input type="email" id="epn_sign_in_modal_email" placeholder="Email" data-toggle="tooltip" data-placement="top"> </div> <h3 class="epn_ux_modal_caption"> <span class="epn_svg ux_https"></span> <span>password</span> </h3> <div class="epn_ux_password "> <button class="epn_ux_show_password"> <span class="epn_svg ux_eye"></span> <span class="epn_svg ux_eye_not"></span> </button> <div class="epn_ux_input epn_no_grey_background"> <input type="password" id="epn_sign_in_modal_password" placeholder="Password" data-toggle="tooltip" data-placement="top"> </div> </div> <div class="epn_group epn_form_footer"> <div class="epn_half"> <button class="epn_form_link epn_form_opener" data-form="epn_reset_password_modal">Change my password</button> <button class="epn_form_link epn_form_opener" data-form="epn_request_magic_link_modal">Get a magic email link</button> </div> <div class="epn_half epn_align_right"> <button class="epn_ux_button" id="epn_sign_in_modal_submit">LOG IN</button> </div> </div> </fieldset> </div> </div> </div> </div> </div> </div> </div> <div class="modal epn_form epn_hidden_soft" tabindex="-1" role="dialog" id="epn_request_magic_link_modal" aria-hidden="true"> <div class="modal-dialog modal-dialog-centered" role="document"> <div class="modal-content"> <div class="epn_overlay epn_hidden_soft"> <div class="epn_loader_spinner epn_solid_gold epn_inside_overlay"></div> </div> <div class="modal-header"> <img src="https://endpts.com/wp-content/themes/endpoints-rakia/assets/svg/epn_logo.svg" alt="Endpoints News"> <button class="epn_form_close" data-dismiss="modal"></button> </div> <div class="modal-body"> <div class="container-fluid"> <div class="row"> <div class="col-8"> <fieldset class="epn_form_content"> <h3 class="epn_ux_modal_caption"> <span class="epn_golden">request magic link</span> </h3> <p>If you're already an Endpoints subscriber, enter your email below for a <b>magic link that lets you log in quickly without using a password</b>. Please note the magic link is <b>one-time use only</b> and expires after 24 hours.</p> <h3 class="epn_ux_modal_caption"> <span class="epn_svg ux_envelope"></span> <span>email</span> </h3> <div class="epn_ux_input epn_no_grey_background"> <input type="email" id="epn_request_magic_link_email" placeholder="E-mail" data-toggle="tooltip" data-placement="top"> </div> <div class="epn_group epn_form_footer"> <div class="epn_half"> <button class="epn_ux_button epn_form_opener" data-form="epn_sign_in_modal">BACK</button> </div> <div class="epn_half epn_align_right"> <button class="epn_ux_button" id="epn_request_magic_link_submit">REQUEST</button> </div> </div> </fieldset> </div> </div> </div> </div> </div> </div> </div> <div class="modal epn_form epn_hidden_soft" tabindex="-1" role="dialog" id="epn_reset_password_modal" aria-hidden ="true"> <div class="modal-dialog modal-dialog-centered" role="document"> <div class="modal-content"> <div class="epn_overlay epn_hidden_soft"> <div class="epn_loader_spinner epn_solid_gold epn_inside_overlay"></div> </div> <div class="modal-header"> <img src="https://endpts.com/wp-content/themes/endpoints-rakia/assets/svg/epn_logo.svg" alt="Endpoints News"> <button class="epn_form_close" data-dismiss="modal"></button> </div> <div class="modal-body"> <div class="container-fluid"> <div class="row"> <div class="col-8"> <fieldset class="epn_form_content"> <h3 class="epn_ux_modal_caption"> <span class="epn_golden">reset password</span> </h3> <p>We'll e-mail you a link to set a new password. Please note this link is one-time use only and is valid for only 24 hours.</p> <h3 class="epn_ux_modal_caption"> <span class="epn_svg ux_envelope"></span> <span>email</span> </h3> <div class="epn_ux_input epn_no_grey_background"> <input type="email" id="epn_reset_password_email" placeholder="E-mail" data-toggle="tooltip" data-placement="top"> </div> <div class="epn_group epn_form_footer"> <div class="epn_half"> <button class="epn_ux_button epn_form_opener" data-form="epn_sign_in_modal">BACK</button> </div> <div class="epn_half epn_align_right"> <button class="epn_ux_button" id="epn_reset_password_submit">RESET</button> </div> </div> </fieldset> </div> </div> </div> </div> </div> </div> </div> <div class="modal epn_form" tabindex="-1" role="dialog" id="epn_subscribe_modal" aria-hidden="true"> <div class="modal-dialog modal-dialog-centered" role="document"> <div class="modal-content"> <div class="epn_overlay epn_hidden_soft"> </div> <div class="modal-header"> <img src="https://endpts.com/wp-content/themes/endpoints-rakia/assets/svg/epn_logo.svg" alt="Endpoints News"> <button class="epn_form_close" data-dismiss="modal"></button> </div> <div class="modal-body"> <div class="container-fluid"> <div class="row"> <div class="col-8"> <div class="epn_form_content"> <h3 class="epn_ux_caption"> <p class="singup_form_p">Sign up for free to read a limited number of articles each month.</p> <span>About You</span> </h3> <fieldset> <div class="epn_ux_input"> <input type="email" id="epn_modal_subscribe_email" placeholder="Email" data-toggle="tooltip" data-placement="top"> </div> <div class="epn_ux_input"> <input type="text" id="epn_modal_subscribe_name" placeholder="Full Name" data-toggle="tooltip" data-placement="top"> </div> <div class="epn_ux_input"> <input type="text" id="epn_modal_subscribe_company" placeholder="Company" data-toggle="tooltip" data-placement="top"> </div> <div class="epn_ux_input"> <input type="text" id="epn_modal_subscribe_job_title" placeholder="Job Title" data-toggle="tooltip" data-placement="top"> </div> </fieldset> <h3 class="epn_ux_caption my-3"> <span>Newsletter Interests</span> <p class="singup_form_p">Pick what newsletters get delivered to your inbox each week.</p> </h3> <fieldset> <p>Biopharma</p> <div class="epn_ux_switch_group epn_white_box"> <p> <span class="epn_subscribe_bold_uppercase">ENDPOINTS NEWS</span> <span class="epn_grey">Daily at 11:30 AM ET</span> </p> <div class="epn_ux_switch"> <input type="checkbox" id="epn_modal_subscribe_endpoints_edition" checked=""> <label for="epn_modal_subscribe_endpoints_edition"></label> </div> </div> <div class="epn_ux_switch_group epn_white_box"> <p> <span class="epn_subscribe_bold_uppercase">EARLY EDITION</span> <span class="epn_grey">Daily at 7:15 AM ET</span> </p> <div class="epn_ux_switch"> <input type="checkbox" id="epn_modal_subscribe_early_edition" checked=""> <label for="epn_modal_subscribe_early_edition"></label> </div> </div> <div class="epn_ux_switch_group epn_white_box"> <p> <span class="epn_subscribe_bold_uppercase">ENDPOINTS PHARMA</span> <span class="epn_grey">Daily at 3:30 PM ET</span> </p> <div class="epn_ux_switch"> <input type="checkbox" id="epn_modal_subscribe_endpoints_pharma" checked=""> <label for="epn_modal_subscribe_endpoints_pharma"></label> </div> </div> <div class="epn_ux_switch_group epn_white_box"> <p> <span class="epn_subscribe_bold_uppercase">BREAKING NEWS ALERTS</span> <span class="epn_grey">2-3 times a week</span> </p> <div class="epn_ux_switch"> <input type="checkbox" id="epn_modal_subscribe_breaking_news_alerts_biopharma" checked=""> <label for="epn_modal_subscribe_breaking_news_alerts_biopharma"></label> </div> </div> <div class="epn_ux_switch_group epn_white_box"> <p> <span class="epn_subscribe_bold_uppercase">ENDPOINTS FDA+</span> <span class="epn_grey">Wed at 2 PM ET</span> </p> <div class="epn_ux_switch"> <input type="checkbox" id="epn_modal_subscribe_endpoints_fda_plus" checked=""> <label for="epn_modal_subscribe_endpoints_fda_plus"></label> </div> </div> <div class="epn_ux_switch_group epn_white_box"> <p> <span class="epn_subscribe_bold_uppercase">ENDPOINTS MANUFACTURING</span> <span class="epn_grey">Thu at 2 PM ET</span> </p> <div class="epn_ux_switch"> <input type="checkbox" id="epn_modal_subscribe_endpoints_manufacturing" checked=""> <label for="epn_modal_subscribe_endpoints_manufacturing"></label> </div> </div> <div class="epn_ux_switch_group epn_white_box"> <p> <span class="epn_subscribe_bold_uppercase">ENDPOINTS WEEKLY</span> <span class="epn_grey">Sat at 6 AM ET</span> </p> <div class="epn_ux_switch"> <input type="checkbox" id="epn_modal_subscribe_endpoints_weekly" checked=""> <label for="epn_modal_subscribe_endpoints_weekly"></label> </div> </div> <div class="epn_ux_switch_group epn_white_box"> <p> <span class="epn_subscribe_bold_uppercase">POST-HOC</span> <span class="epn_grey">1-2 times a week</span> </p> <div class="epn_ux_switch"> <input type="checkbox" id="epn_modal_subscribe_post_hoc_biopharma" checked=""> <label for="epn_modal_subscribe_post_hoc_biopharma"></label> </div> </div> <p class="mt-4">Healthcare</p> <div class="epn_ux_switch_group epn_white_box"> <p> <span class="epn_subscribe_bold_uppercase">ENDPOINTS HEALTH TECH</span> <span class="epn_grey">Tuesday, Thursday at 10 AM ET</span> </p> <div class="epn_ux_switch"> <input type="checkbox" id="epn_modal_subscribe_endpoints_health_tech" checked=""> <label for="epn_modal_subscribe_endpoints_health_tech"></label> </div> </div> <div class="epn_ux_switch_group epn_white_box"> <p> <span class="epn_subscribe_bold_uppercase">BREAKING NEWS ALERTS</span> <span class="epn_grey">2-3 times a week</span> </p> <div class="epn_ux_switch"> <input type="checkbox" id="epn_modal_subscribe_breaking_news_alerts_healthcare" checked=""> <label for="epn_modal_subscribe_breaking_news_alerts_healthcare"></label> </div> </div> </fieldset> <div class="epn_group mt-4"> <button class="epn_ux_button epn_has_tooltip no_tooltip_on_hover" id="epn_modal_subscribe_submit" data-toggle="tooltip" data-placement="top">INSTANT SIGN UP</button> <p>Want <b>unlimited access</b>? <a href="https://endpts.com/upgrade/" target="_blank" >Sign up</a> for a premium subscription plan.</p> </div> </div> </div> </div> </div> </div> </div> </div> </div> <script src="https://endpts.com/wp-content/themes/endpoints-rakia/assets/js/jquery.min.js?ver=3.7.1" id="jquery-js"></script> <script src="https://endpts.com/wp-content/themes/endpoints-rakia/assets/js/ca_animator.min.js?ver=1526505728" id="ca_animator-js"></script> <script src="https://api.stats.endpts.com/assets/client.min.js?ver=2506754750" id="ep-sClient-js"></script> <script src="https://endpts.com/wp-content/plugins/endpoints/assets/js/tUtils.min.js?ver=2506754750" id="ep-tUtils-js"></script> <script src="https://endpts.com/wp-content/themes/endpoints-rakia/assets/js/bootstrap.bundle.min.js?ver=4.6.2" id="bootstrap_js-js"></script> <script id="rakia_script-js-extra"> var EP_ajax_object = {"ajax_url":"https:\/\/endpts.com\/wp-admin\/admin-ajax.php","assets":"https:\/\/endpts.com\/wp-content\/plugins\/endpoints\/assets\/","fallback_spinner":"https:\/\/endpts.com\/wp-content\/plugins\/endpoints\/assets\/images\/loading.gif","products":["earlyEdition","endpointsEdition","endpointsPharma","endpointsFDAPlus","endpointsManufacturing","endpointsWeekly","breakingNewsAlertsBiopharma","endpointsHealthTech","excludeSpecialReportsCommunications","excludeEventsCommunications","excludeWebinarsDigestCommunications","excludePartnerMarketingCommunications","excludeCompanyUpdatesCommunications","breakingNewsAlertsHealthcare","postHocBiopharma"],"statsAPI":"https:\/\/api.stats.endpts.com","intercom":"1","user_type":"Guest"}; </script> <script src="https://endpts.com/wp-content/themes/endpoints-rakia/assets/js/script.min.js?ver=1526505728" id="rakia_script-js"></script> <script id="dfp-js-extra"> var ad_units_data = {"\/21729248569\/rakia_banner_above_articles":{"div":"rakia_above_articles","sizes":[[970,250],[340,120],[340,150],[340,200],[720,120],[720,150],[720,200],[1200,150],[1200,200],[1200,250],[300,250]]},"\/21729248569\/rakia_banner_below_articles":{"div":"rakia_below_articles","sizes":[[970,250],[340,120],[340,150],[340,200],[720,120],[720,150],[720,200],[1200,150],[1200,200],[1200,250],[300,250]]},"\/21729248569\/rakia_banner_above_tiles_homepage":{"div":"rakia_above_tiles","sizes":[[970,250],[340,120],[340,150],[340,200],[720,120],[720,150],[720,200],[1200,150],[1200,200],[1200,250],[300,250]]},"\/21729248569\/rakia_banner_ipo_tracker_billboard":{"div":"rakia_ipo_tracker_billboard","sizes":[[970,250],[340,120],[340,150],[340,200],[720,120],[720,150],[720,200],[1200,150],[1200,200],[1200,250],[300,250]]},"\/21729248569\/rakia_banner_ipo_tracker_instream":{"div":"rakia_ipo_tracker_instream","sizes":[[970,250],[340,120],[340,150],[340,200],[340,230],[720,120],[720,150],[720,200],[1200,150],[1200,200],[1200,250],[300,250]]},"\/21729248569\/rakia_banner_below_tiles_homepage":{"div":"rakia_below_tiles","sizes":[[970,250],[340,120],[340,150],[340,200],[720,120],[720,150],[720,200],[1200,150],[1200,200],[1200,250],[300,250]]},"\/21729248569\/rakia_within_article":{"div":"rakia_within_article","sizes":[[340,150],[340,200],[340,230],[340,250],[440,150],[440,190],[440,200],[760,150],[760,200],[760,250],[300,250]]},"\/21729248569\/rakia_instream":{"div":"rakia_in_stream","sizes":[[340,150],[340,200],[340,230],[340,250],[520,150],[520,200],[520,220],[890,150],[890,200],[890,250]]},"\/21729248569\/rakia_sponsored_front_page":{"div":"rakia_sponsored_front_page","sizes":[[340,570],[340,595],[592,305]]},"\/21729248569\/rakia_banner_above_tiles_channels":{"div":"rakia_above_tiles_channel","sizes":[[970,250],[340,120],[340,150],[340,200],[720,120],[720,150],[720,200],[1200,150],[1200,200],[1200,250],[300,250]]},"\/21729248569\/rakia_banner_below_tiles_channels":{"div":"rakia_below_tiles_channel","sizes":[[970,250],[340,120],[340,150],[340,200],[720,120],[720,150],[720,200],[1200,150],[1200,200],[1200,250],[300,250]]},"\/21729248569\/rakia_inarticle_adx":{"div":"rakia_within_article_adx","sizes":[[300,100],[300,250],[320,100],[336,280],[468,60],[728,90]]},"\/21729248569\/rakia_instream_adx":{"div":"rakia_in_stream_adx","sizes":[[300,100],[300,250],[320,100],[336,280],[468,60],[728,90]]},"\/21729248569\/rakia_article_page_fsp_ad":{"div":"rakia_article_page_fsp_ad","sizes":[[896,670],[345,860]]},"isadx":"<section class=\"epn_regular_section epn_instream_ad epn_ad_wrapper\"><div id=\"ridis\" data-slot=\"\/21729248569\/rakia_instream_adx\"><\/div><\/section>","iaadx":"<div class=\"epn_ad_wrapper\"><div class=\"epn_article_ad\" id=\"ridia\" data-slot=\"\/21729248569\/rakia_inarticle_adx\"><\/div><\/div>"}; </script> <script src="https://www.googletagservices.com/tag/js/gpt.js" id="dfp-js"></script> <script src="https://endpts.com/wp-content/plugins/endpoints/assets/js/endpoints.min.js?ver=2506754750" id="ep_script-js"></script> <script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"bam.nr-data.net","licenseKey":"NRJS-0a161597335a680ce50","applicationID":"717633112","transactionName":"YlVSMUZUCxVQV0NcWVsfcQZAXAoIHlJFWlhBHUAEU1A=","queueTime":0,"applicationTime":270,"atts":"ThJRRw5OGBs=","errorBeacon":"bam.nr-data.net","agent":""}</script></body> </html>

CINXE.COM

Endpoints News – Biotech and pharma business news, with a focus on the science, people and money that drive the industry.